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STUDY OUTLINE 
 
This masters dissertation is presented in article format, with one study and four chapters. 
A background has been included to orientate the reader to the overall view of the study problem, 
statements, as well as our aims. Chapter one is a literature review which is a general discussion based 
on the topics covered in the study. Chapter two contains the manuscript submitted to Journal of 
Neuroscience Methods. The manuscript is written in accordance to the journal guidelines. Chapter 
three contains the overall synthesis for the study, as well as future recommendations. Chapter four 
contains additional appendices. 
  
xi 
 
ABSTRACT 
Introduction 
Febrile seizures are a neurological abnormality that occurs after an underlying systemic infection, 
leading to fever and followed by convulsions due to neuronal hyper-excitability. Although regarded as 
benign, prenatal stress, prominent in third world countries, has been shown to exacerbated febrile 
seizures in offspring by dysregulating the hypothalamus-pituitary-adrenal axis, subsequently leading 
to increased production of prostaglandin E2 (PGE2) in the preoptic nuclei region of the hypothalamus. 
Current animal models used to mimic febrile seizures include but are not limited to, 
lipopolysaccharide (LPS) and kainic acid (KA) administration, or exposure to a hyperthermic 
environment. However, these models often result in 50% seizure onset with high mortality rates. 
Therefore, the aims of this study were to refine the models and assess the effects of prenatal stress. 
Materials and Methods 
Pregnant Sprague Dawley dams were exposed to restraint stress in their third trimester, and febrile 
seizures induced in the subsequent pups on postnatal day 14 by one of 2 models i.e. 1. Inducing febrile 
seizure using the LPS and KA method and 2. via exposure to a hyperthermic environment. Seizures 
were scored 0 to 5 on a Racine scale. Hypothalamic tissue was harvested and assessed for PGE2 and its 
receptor (EP3R) concentrations by means of ELISA and PCR respectively. 
Results 
Our findings show that modifying the dose to 50 µg/kg LPS and 0.44 mg/kg KA significantly 
decreased mortality, and thus proved to be most effective. We were also able to induce convulsions 
through the hyperthermic model. Additionally, we showed that exposure to prenatal stress 
significantly exacerbated fever and seizure severity, and increased EP3R concentrations. 
 
Conclusion and Relevance 
The modified LPS-KA and heat models both proved sufficient in inducing convulsions, with 
drastically reduced mortality rates for both stressed and non-stress rat offspring. Albeit it was slightly 
less severe than previously reported, these simple benign seizures more accurately mimic simple 
febrile seizures most often experienced by otherwise healthy infants and young children. The 
hyperthermic model, although sufficient in inducing seizures and maintaining survival, was unable to 
mimic fever though the appropriate PGE2 release, and thus the modified LPS-KA model was selected 
as the most effective and most efficient model to use in order to study febrile seizures. 
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BACKGROUND 
It is estimated that the global prevalence of febrile seizures is 3 - 5% of the population, with sub-
Saharan Africa showing an alarmingly higher prevalence of 0.8 - 31% (1-3). It is the most common 
convulsive disorder in neurologically healthy children under the age of 6 (4). A febrile seizure is a 
neurological abnormality that occurs after an underlying systemic infection, leading to an elevation in 
core body temperature know as a fever, followed by neuronal hyper-excitability and thus convulsions 
(5-7). This elevated body temperature is often caused by upper respiratory tract, middle and inner ear, or 
gastrointestinal tract infections which trigger the onset of febrile seizures (7, 8). Febrile seizures are 
most often associated with general influenza (9), but are also associated with roseola virus infections 
such as human herpesvirus-6, as well as after some childhood immunizations (10-12). It should be noted 
however that the immunisations themselves do not increase the risk of febrile seizures, but rather the 
fever often experienced afterwards (13, 14). 
 
The systemic immune response to the above mentioned infections mobilize the release of various 
proinflammatory cytokines (15) such as interleukin-1 beta, interleukin 6, and tumour-necrosis factor 
alpha (16). Due to the increased production and release of these proinflammatory cytokines, the blood 
brain barrier becomes compromised resulting in a neurotransmitter imbalance between glutamate and 
γ-aminobutyric acid (GABA)  triggering the onset of convulsions (17, 18). Interleukin-1 beta (IL-1β), a 
fever promoting pyrogen (19-21), has been shown to play a pivotal role in febrile seizure development 
during infection (5) by activating cyclooxygenase-2 (COX-2) to catalyse the conversion of arachidonic 
acid into prostaglandin E2 (PGE2) in the preoptic nuclei (16). The preoptic nuclei, or preoptic area 
(POA) is found in the rostral most part of the hypothalamus (22) and is often referred to as the fever 
centre (6). PGE2 acts to induce fever by inhibiting preoptic warm-sensitive neurons and increasing 
preoptic cold-sensitive neurons, thus suppressing heat loss and enhancing heat production and 
retention respectively (6, 23). This effectively elevates the hypothalamic set-point temperature, leading 
to fever (6, 23). 
 
Numerous studies have been conducted in our laboratory attempting to understand factors that 
perpetuate febrile seizures and if neuronal malfunctions can result from these convulsions. Our 
findings have shown that febrile seizures resulted in neuronal developmental malformation and 
behavioural changes (7, 19, 20, 24). Furthermore, we have shown that exposure to prenatal stress resulted 
in exacerbated febrile seizures in rat offspring through increased cytokine production, subsequently 
leading to more pronounced malformations (7, 21). Prenatal stress accounts for all types of stress, i.e. 
emotional and or physical stress experienced by pregnant mothers, with the most prominent effects 
occurring during their last trimester of pregnancy (7, 19, 21). 
 
xiii 
 
A wide range of animal models have been adapted to study the effects of febrile seizures, e.g. 
administration of various chemoconvulsants, electrical stimulation, or exposure to heated 
environments (7, 19, 20, 25-27). Our laboratory adapted the Heida et al. (2005) (3) chemoconvulsants model, 
whereby febrile seizures are induced in 14 day old rats with a combination of lipopolysaccharide 
(LPS) and kainic acid (KA) to mimic infection and convulsions respectively. Heida et al. (2005) 
obtained febrile seizures in at least 50% of animals without recurrent seizures using 200μg/kg of LPS 
followed 2 h 30 min later by 1.75mg/kg of KA administered intraperitoneally (3). The model is 
effective in inducing febrile seizures, however it has a high mortality rate. This lead us to refine the 
Heida et al. (2005) (3) model, as well as to the introduce a hyperthermic model based on previous 
models by Jiang et al. (1999) (28) and Yagoubi et al. (2015) (29), for use in our laboratories. In these 
hyperthermic models, young rats ranging from 10 to 15 days old were placed in heated environments 
for a brief period to increase core body temperature. In each case, as soon as signs of seizures 
occurred, the rats were removed from the hyperthermic environment, placed on a cool surface and 
observed for seizure activity (29-32). 
 
Thus, the focus of this study was to: 
 
1. Determine the most effective and efficient dose of LPS and KA to induce febrile seizures 
in rats, while maintaining a high survival rate. 
2. Determine the most effective and efficient LPS-KA and hyperthermia based animal 
models of febrile seizure to be used in our laboratory. 
3. Assess the neurochemical effect of prenatal stress on PGE2 and its receptor EP3R 
concentration in hypothalamic tissue of LPS-KA and hyperthermia based animal models 
of febrile seizure. 
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CHAPTER ONE 
Chapter one contains the literature review for this manuscript. The literature review covers febrile 
seizure epidemiology, pathophysiology, as well as relevant cytokines that lead to fever and 
convulsions. The literature review also discusses various animal models used to study febrile seizures. 
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LITERATURE REVIEW 
EPIDEMIOLOGY 
The American Academy of Paediatrics (AAP) defines febrile seizures as seizures that occur during 
fever in the absence of a history of afebrile seizures, metabolic disturbance, intracranial infection or 
any other central nervous system (CNS) infections (1). Globally, febrile seizures are experienced by 2 - 
5% of children between the ages of 3 months to 6 years (1-4), and 0.8 - 31% of children in sub-Saharan 
Africa (5), with a peak incidence around 18 months of age (6). Africa has shown a growing prevalence 
of acute seizures with risk factors including, poor sanitation, malnutrition, inadequate medical 
facilities and resources, as well as insufficient knowledge (4, 7, 8). These deficiencies leave children at 
higher risk of systemic infections such as middle ear infection, gastroenteritis and upper respiratory 
tract infections that result in fever (4, 7, 8). Febrile seizures may arise from the ensuring systemic fever 
occurring as a result of these above mentioned infections, thereby evoking excessive neuronal impulse 
firing that may result in convulsions (8, 9). 
 
Febrile seizures can be divided into three main categories i.e. simple or complex febrile seizures, and 
status epilepticus (5, 6, 8). Simple febrile seizures last 1-2 minutes and have a clear focus of infection (3). 
Complex febrile seizures last 15-30 minutes and may reoccur within a single fever episode, while 
status epilepticus occurs arbitrarily in the brain during a febrile infection, lasts longer than 30 minutes, 
and reoccurs within a 24 h window (6, 8, 10). Complex febrile seizures and status epilepticus have been 
known to develop into more severe conditions such as temporal lobe epilepsy (TLE) (2, 6, 8, 9, 11, 12). A 
50% increased risk for epilepsy was found in neonates that had a family history of TLE, had complex 
febrile seizures or those that had neurodevelopmental impairments (11). According to the National 
Health Service (NHS, UK, 2018) it is estimated that healthy children have a 1% chance of developing 
epilepsy later in life, as compared to a 2% and 5% chance for those who experience simple and 
complex febrile seizures respectively (13). 
FEBRILE SEIZURE PATHOPHYSIOLOGY 
Febrile seizures occur with the activation of the inflammatory immune response to an insult, thereby 
releasing activated leukocytes such as macrophages and neutrophils, which in turn release pro-
inflammatory cytokines, predominantly interleukin-1 beta (IL-1β), interleukin 6 (IL-6) and tumour-
necrosis factor alpha (TNFα) to attack the invading pathogen through the process of inflammation (8, 
12). High levels of these combined peripheral cytokines compromise the endothelial cells of the BBB, 
thus making it leaky and susceptible to higher levels of entering cytokines (8, 14). IL-1β has been shown 
to play a pivotal role in febrile seizure development through binding interleukin-1 receptors (IL-1R) in 
microglia, allowing an increased influx into the CNS (8). 
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The increase of IL-1β in the CNS triggers the enzyme cyclooxygenase-2 (COX-2) which catalyses the 
conversion of arachidonic acid into prostaglandin E2 (PGE2), at the organum vasculosum laminae 
terminalis (8, 12, 15-18). The organum vasculosum laminae terminalis is surrounded by the preoptic nuclei 
in the hypothalamus, which lacks a complete BBB, thus allowing PGE2 to easily enter and stimulate 
the neural pathways that raise body temperature (8, 15, 19, 20). 
 
The hypothalamus is comprised of 4 regions, the most rostral being the preoptic region, followed by 
the supraoptic or anterior region, the tuberal region and finally the mammillary region (21). The 
preoptic nuclei or preoptic area (POA) is found in the rostral part of the hypothalamus and is split into 
13 nuclei regions (21). It is most often referred to as the thermoregulatory hub as well as the fever 
centre as it is this brain area that increases the core body temperature during a fever (22). In order to 
trigger the fever producing mechanism, PGE2 acts on prostaglandin EP3 (EP3R) receptors 
predominantly in the medial and median preoptic nuclei regions (23). The POA also plays a role in the 
sleep wake cycle, reproductive and maternal behaviour, as well as cardiovascular responses and fluid 
homeostasis (21). 
 
In normal non febrile circumstances, there is a negative feedback mechanism provided by the anti-
inflammatory cytokine interleukin-1 receptor antagonist (IL-1Ra) that promotes homeostasis by 
competitively binding to the same receptors as IL-1β, thus modulating IL-1β mediated production of 
PGE2 and subsequently reducing the fever response (8, 15, 22). During febrile seizures however, due to 
the increased concentration of IL-1β, its binding is favoured over its antagonist IL-1Ra by microglia 
IL-1R, resulting in its excess influx into the CNS, subsequently ramping up PGE2 production (8, 10, 14, 
24). 
Elevated IL-1β concentrations in the CNS and particularly in the brain causes a neurotransmitter 
imbalance that favours glutamate and inhibits gamma-aminobutyric acid (GABA), an inhibitory 
neurotransmitter in the hippocampus (8, 16, 25). Glutamate is an excitatory neurotransmitter and exerts its 
effects by binding to and activating cell surface receptors that open membrane channels allowing 
charged ions i.e. Ca2+, Cl-, K+ and NA+ to pass through (26). This leads to neuronal hyper-excitability as 
well as neuronal death due to over activation of the glutamate receptors resulting in excessive neuronal 
firing rates (8, 16, 25). 
THE IMMUNE SYSTEM AND INFLAMMATION 
Febrile seizures usually begin with the activation of the immune system resulting from an underlying 
infection. The human immune system is a complex layered network of organs, tissues, specialized 
cells and proteins, that protects the body from invading pathogens by eliciting an inflammatory 
response (27, 28). It is well accepted that the immune system can be divided into two segments: the 
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innate immune system which is non-specific, and the adaptive immune system, activated by the first, 
which is specific and also has memory (29-31). 
The innate immune system is the first to respond to an invading pathogen e.g. bacterial infections, by 
employing a group of proteins known as cytokines released from phagocytic immune cells, namely 
macrophages, neutrophils and dendritic cells (2, 27, 28). These activated cells migrate to the site of injury 
via chemotaxis, in an innate immune system process known as inflammation (32, 33). Inflammation 
requires the involvement of these immune cells, surrounding blood vessels, and the released molecular 
mediator proteins to both eliminate the initial cause of injury as well as the damaged cells, and to 
initiate tissue repair (33, 34). Immune cells possess surface pattern recognition receptors (PRRs) that 
allow it to recognise either pathogen-associated molecular patterns (PAMPs) found on various 
pathogens cell membranes, or damage-associated molecular patterns (DAMPs) found on damaged host 
cell membranes (33-36). Activation of immune cell PRRs through binding to either PAMPs or DAMPs 
leads to the recruitment of additional immune cells, and the release of molecular mediator proteins to 
initiate the classic inflammatory reaction, first recognized by Celsus over 2,000 years ago, i.e. rapid 
swelling (tumor), redness (rubor), pain (dolor), and heat (calor) (35, 37), as well as loss of function 
(functio laesa) later added by Galen. The rapid infiltration of additional immune cells allows for the 
rapid removal of pathogens, and for tissue repair, thereby returning to a state of homeostasis (29-31). If 
this first line of response fails, the adaptive immune response is activated (28, 38, 39). 
Adaptive immunity, based on antigen-specific responses of T and B lymphocytes, creates a specific 
immunological memory of the response to that particular pathogen thereby enhancing the body’s 
defence against future insult of that pathogen (28, 38, 39). Depending on the severity of the insult, the 
adaptive immune system will, or will not be activated during a febrile response, but its involvement 
will not be considered for the development of a febrile seizure in this study. 
 
Although febrile seizures start with the activation of the immune system, it is the compromised BBB 
that allows the influx of proinflammatory cytokines into brain tissue that ultimately results in the fever 
and convulsions experienced during febrile seizures. 
THE BBB AND NEUROINFLAMMATION 
The neuroimmune system, like the immune system, consists of structures and processes that link the 
immune system to the central nervous system (CNS), consisting of the brain, spinal cord and the 
neuroimmune system. The neuroimmune system involves biochemical and electrophysiological 
interactions to protect neurons from pathogens and disease by maintaining highly selective permeable 
barriers i.e. the blood brain barrier (BBB), as well as mediating neuroinflammation and wound healing 
by mobilizing host defences (40, 41). During a febrile seizure, high levels peripheral proinflammatory 
cytokines compromise the endothelial cells of the BBB, thus making it leaky and susceptible to higher 
levels of entering cytokines (8, 14). 
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The key cellular components of the neuroimmune system are glial cells, which include astrocytes, 
oligodendrocytes, and the most prominent glial cells in the CNS, microglia (42). The concept of 
Microglia was first introduced in 1932 by Pio del Rio-Hortega in a book titled ‘Cytology and Cellular 
Pathology of the Nervous System’ under a chapter titled ‘Microglia’ which covered his research 
published in a series of papers between 1919 and 1927 (43, 44). Pio del Rio-Hortega (1932) (45) 
postulated 9 key aspects of microglia that hold true today, even after much research in the preceding 
years, i.e. ‘1) microglia enter the brain during early development. 2) These invading cells have 
amoeboid morphology and are of mesodermal origin. 3) They use vessels and white matter tracts as 
guiding structures for migration and enter all brain regions. 4) They transform into a branched, 
ramified morphological phenotype in the more mature brain (known today as the resting microglia). 5) 
In the mature brain, they are found almost evenly dispersed throughout the central nervous system and 
display little variation. 6) Each cell seems to occupy a defined territory. 7) After a pathological event, 
these cells undergo a transformation. 8) Transformed cells acquire amoeboid morphology similar to 
the one observed early in development. 9) These cells have the capacity to migrate, proliferate and 
phagocytose.’ Taken from a paper published by Kettenmann et al. (2011) (44). In this way, microglia 
act as the innate immune cells of the CNS and are the brains first line of defence once the BBB has 
been compromised i.e. during a febrile infection, and once activated, they migrate and surround the 
injury site to clear it, much like inflammation throughout the body (34, 46-52). Activated microglial, like 
leukocytes, release various proinflammatory mediators including arachidonic acid, cytokines, 
chemokines, complement proteins, and reactive oxygen and nitrogen species that also directly 
contribute to neuroinflammation and injury (53, 54). 
 
The BBB is a diffusion barrier between the brain and the circulating blood, and is essential for the 
normal function of the CNS (55, 56). The BBB is made up of specialised endothelial cells with more 
extensive tight junctions than those found throughout the body, allowing for highly selective transport 
of molecules, ions, and cells in order to regulate homeostasis, and to provide protection e.g. from 
toxins, pathogens, inflammation, injury, and even disease (55-58). A compromised BBB, as the result of 
excess IL-1ß during a febrile seizure, may result in altered signalling, allowing excess immune cell 
infiltration, leading to neuroinflammation, dysregulation and often degeneration (55-58). 
INTERLEUKIN-1 BETA (IL- 1ß) 
Eleven ligands make up the interleukin-1 (IL-1) family, including two proinflammatory ligands, 
interleukin-1 alpha (IL-1α) and IL-1β, and their naturally occurring antagonist, IL-1Ra, that play a 
central role in the regulation of the immune inflammatory response (59-62). IL-1α and IL-1β both bind to 
the same receptor molecule IL-1 receptor 1 (IL-1RI), that recruits a necessary coreceptor IL-1 receptor 
accessory protein (IL-1RAcP) to induce further cascades to initiate inflammation (59, 62, 63). 
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In order to modulate the inflammatory response, IL-1Ra competitively binds the same IL-1RI, 
however does not recruit IL-1RAcP, and therefore does not initiate signalling to cause inflammation 
(24, 59-63). In relation to neuroinflammation experienced during a febrile seizure, excess IL-1β is able to 
cross the compromised BBB by competitively binding to IL-1RI in the CNS, and trigger COX-2 to 
induce inflammation and fever through activation of pyretic prostaglandins, particularly PGE2 (8, 15, 63). 
CYCLOOXYGENASE-2 (COX-2) INDUCED PROSTAGLANDIN PRODUCTION 
COX-2, an enzyme responsible for the formation of prostaglandins (64) can be found in high 
concentrations in the CNS, where it participates in the early response to pro-inflammatory mediators 
and stimuli during an inflammatory response (65-70). Infectious organisms e.g. high levels of 
proinflammatory cytokines such as IL-1β, stimulate the overexpression of COX-2 in endothelial cells 
of the BBB (69-73). COX-2 was found by Smith and Lands (1972) (74), and Hamberg et al. (1974) (75), to 
be the major enzyme involved in the oxidative conversion of arachidonic acid (AA) into 
prostaglandins. In relation to inflammation and fever, COX-2 catalyses the conversion of arachidonic 
acid into the pyretic prostaglandin PGE2, that subsequently induces the preoptic nuclei of the 
hypothalamus to increase core temperature (15, 16, 19, 67, 73, 76). 
 
Prostaglandins are lipid metabolites produced from the conversion of arachidonic acid by COX-2, and 
play a major role in inflammation and pain in the body (65, 73, 76). Arachidonic acid, a polyunsaturated 
fatty acid found in the phospholipid membrane of cells and derived from dietary sources, is converted 
to prostaglandin H2 (PGH2) by hydrolysed phospholipids via the enzyme phospholipase A2, which can 
be upregulated via hormonal stimulation (65, 73, 77). The exact mechanism by which PGE2 is synthesised 
from PGH2 is not well understood, but it is evident than many prostaglandin synthesised products act 
in conjunction with cyclooxygenase to produce the target prostaglandins (15, 19, 22, 77-79). The pyrexia-
producing PGE2 is formed by COX-2, as it was also shown by Li et al. (1999) (80) that mice 
administered with COX-2 inhibitors fail to produce fever when treated with LPS. The pyretic action of 
PGE2 is mediated by the EP3R receptor, as it was shown by Ushikubi et al. (1998) (81) that mutant mice 
lacking EP3R do not develop fever after administration of PGE2. 
For the purpose of this study, we measured PGE2 and its receptor EP3R concentrations in 
hypothalamic tissue as a means to identify fever progression, which was taken into consideration when 
selecting the most appropriate rat model of febrile seizure. 
FEVER 
"Heat is the immortal substance of life endowed with intelligence. . . . However, heat must also be 
refrigerated by respiration and kept within bounds if the source or principle of life is to persist; for if 
refrigeration is not provided, the heat will consume itself" 
Hippocrates (82) 
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Fever, known also as pyrexia or a febrile response, provoked by infection, is thought to provide an 
optimal hyperthermic environment for enhancing host defences by increasing mobility and enhancing 
leukocyte phagocytosis, all the while reducing the pathogens viability (21, 76). During fever generation, 
PGE2, a powerful endogenous pyrogenic mediator of the POA binds to EP3R  on a population of 
GABAergic neurons in the POA (22, 83). The binding of PGE2 to EP3R is responsible for the febrile 
response as it was shown by Morrison et al. (2011) that EP3R deletion in neurons distributed in the 
POA suppressed most of the febrile response to PGE2 (22). PGE2 acts to induce fever by inhibiting the 
firing rate of preoptic warm-sensitive neurons, therefore suppressing heat loss, as well as increasing 
the firing rate of cold-sensitive neurons to enhance heat production and retention (15). This effectively 
elevates the hypothalamic set-point temperature, leading to fever (15, 22). Apart from fever, febrile 
seizures also present with convulsive activity due to excessive neuronal firing driven by the increased 
influx of IL-1β into the CNS resulting in the imbalance of two key neurotransmitters, i.e. glutamate 
and GABA. 
GLUTAMATE AND GAMMA-AMINOBUTYRIC ACID (GABA) IMBALANCE RESULTS IN CONVULSIONS 
Two key neurotransmitters in the brain include glutamate and GABA that control excitatory and 
inhibitory neurotransmission respectively (84-88). During a febrile seizure, elevated plasma 
concentrations of IL-1β causes an imbalance between these two neurotransmitters, favouring 
glutamate, and inhibiting GABA, resulting in neuronal hyperexcitability and death (8, 16, 25, 89, 90). 
Glutamate is the predominant excitatory neurotransmitter of the adult mammalian brain, and mediates 
its effects through ionotropic and metabotropic receptor subclasses (84, 91). Ionotropic glutamate 
receptors are dependent on ionic gradients, and include the fast α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptor (AMPAR), the slow N-methyl-D-aspartate (NMDAR) receptor, as 
well as kainate receptors (KAR) (84, 92). Metabotropic glutamate receptors require secondary messenger 
G-protein coupling in order to translate signals, and often modulate ionotropic receptors (18, 93, 94). In 
relation to febrile seizures, activation of NMDAR causes an influx of calcium ions (Ca2+) into the 
neuron after which it is then removed from the cytoplasm by mitochondria (92, 95, 96). However, excess 
glutamate-stimulated influx of Ca2+ and uptake by mitochondria can lead to neuronal damage and 
eventual cell death, known as excitotoxicity (92, 95, 96). 
 
Under normal circumstances, GABA controls glutamate transmission and acts as a negative feedback 
mechanism by activating GABAA receptors to regulate chloride ions (Cl-), and GABAB receptors to 
decreases Ca2+ conductance, and increase membrane conductance of potassium ion (K+) transmission, 
thereby modulating the effects of glutamate (97-100). GABA, the main inhibitory neurotransmitter in the 
CNS was first shown by Roberts, Frankel and Udenfriend in 1950 to be derived from the breakdown 
of glucose to glutamate, which then serves as a precursor to GABA. GABA is often the first 
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neurotransmitter detected during development, and is thus thought to initially have an excitatory role 
in early brain development (101, 102), but mostly inhibitory in the mature mammalian brain (86, 88). 
 
Excess IL-1ß produced during febrile seizures however has been shown to decrease levels of GABAA 
receptor mediated currents, further establishing an imbalance contributing to seizure generation (18, 97, 
100, 103). Elevated plasma IL-1β also alters the hypothalamus–pituitary–adrenal (HPA) axis thus 
resulting in increased amounts of the glucocorticoid cortisone being released in the plasma, thus 
exacerbating both fevers and seizures (14). Furthermore, these seizures often exacerbated through 
prenatal stress, have been shown to lead to cognitive and behavioural deficits later in life, as well as 
increased susceptibility to epilepsy (8, 14). 
PRENATAL STRESS 
There is increasing evidence to suggest that the prenatal environment can influence foetal 
development, immunity, and response to further stressors later in life (10, 104-109). It has previously been 
shown that high levels of glucocorticoids may influence neurotransmitter release (92), suggesting that 
stress can increase the risk of developing febrile seizures (110). Exposure to prenatal stress during the 
third trimester has also been shown to exacerbate febrile seizures in rat offspring (14). 
Stress, as described by McEwan generally refers to experiences that cause feelings of anxiety and 
frustration (111). Prenatal stress accounts for all types of stress, i.e. emotional and or physical stress 
experienced by pregnant mothers, with the most prominent effects occurring during the last trimester 
(10, 14, 112). Prenatal stress has also been shown to lead to generalized anxiety, depression, deficits in 
attention and learning, and more serious conditions such as autism and schizophrenia (107, 113-116). 
Prenatal stress is also associated with an increased risk of premature birth (117), and emotional and 
cognitive deficits in early life (10, 118-120). Women exposed to stress during pregnancy are also 
themselves at higher risk of developing various diseases and psychological distress (107, 108, 120, 121). The 
primary hormones responsible for regulating the stress response in humans are glucocorticoids and 
adrenaline, produced by the HPA axis, stimulating the body’s “fight or flight” response (122-124). 
THE HPA-AXIS AND THE SYNTHESIS OF CORTISOL 
The HPA axis, a major neuroendocrine system consists of three components, the hypothalamus, 
pituitary gland, and the adrenal glands that work together via direct influences and feedback 
interactions (125, 126). The HPA axis plays a central role in regulating homeostatic systems in the body, 
i.e. the metabolic, cardiovascular, immune, reproductive and central nervous systems (125, 126). In 
maintaining these systems, it thereby regulates bodily processes such as digestion, mood and 
emotions, sexuality, and most importantly it controls the body’s reaction to stress allowing for 
adaptation and ultimately survival (125, 126). 
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Upon a stressor e.g. prenatal stress, the paraventricular nucleus within the mothers hypothalamus 
releases the neurohormone corticotrophin-releasing hormone (CRH), into the hypophysial portal blood 
vessels connecting the hypothalamus and the pituitary gland (127, 128). This neurohormone then 
stimulates the anterior pituitary gland to produce and secrete adrenocorticotropic hormone (ACTH) 
into the blood circulation (127, 128). The ACTH activates glucocorticoid synthesis and release from the 
cortex of the adrenal glands, which are found atop the kidneys (128). Glucocorticoids bind to 
glucocorticoid and mineralocorticoid receptors found throughout the CNS, which under normal 
circumstances acts as a negative feedback mechanism to control glucocorticoid concentrations by 
inhibiting further cortisol release (127, 128). 
Circulating glucocorticoids are predominantly protein bound to corticosteroid binding globulin, but at 
high stress levels, binding proteins become saturated, resulting in high levels of free glucocorticoid 
that continuously binds and activates its receptors (127). The altered, over stimulated HPA axis then 
often malfunctions, leading to excess glucocorticoid production (107, 109). Glucocorticoids are lipophilic, 
and can therefore freely cross the placenta, especially once it has become leaky due to decreased 
11beta-hydroxysteroid-dehydrogenase 2 (11β-HSD-2) concentrations (14, 118). 
ROLE OF PLACENTAL 11ß -HSD-2 
Under normal circumstances, foetal glucocorticoid levels are about 10-fold lower than maternal levels, 
due to the actions of placental 11β-HSD-2, an enzyme that converts cortisol (corticosterone in rats) to 
its inactive form cortisone (dehydrocorticosterone in rats) (127, 129). The concentration of 11β-HSD-2 
increases with advancing gestation thus limiting foetal glucocorticoid exposure during critical stages 
of development (127). The concentration of 11β-HSD-2 however decreases during the third trimester in 
preparation for parturition and lung maturation, thus allowing an increased influx of the mother’s 
glucocorticoids into the foetus (14, 118, 127). Excess cortisol exposure in utero is associated with increased 
activity of the offspring’s HPA axis (127), thus higher maternal cortisol levels in the third trimester are 
associated with increased cortisol response in the new-born to light stress (118, 127). 
 
Maternal malnutrition, stress or illness is further associated with down regulation of 11β-HSD-2 
mRNA expression thus increased placental glucocorticoid sensitivity, further allowing cortisol entry to 
the foetus (127). Due to increased levels of the cortisol perforating though the placental barrier, the 
developing foetus’s HPA axis may become dysregulated (105, 107, 108). This dysfunction of the HPA axis 
leaves the new-born more sensitive to future stress, resulting in even higher cortisol exposure or 
greater cortisol burden following each stressful episode (118, 121, 127, 128) leaving the neonate offspring 
more prone to infection than non-prenatally stressed neonates (76, 107). 
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As exposure to prenatal stress during the third trimester has been shown to exacerbate febrile seizures 
in rat offspring, we also included a stress factor in this study to further test this theory (14). Prenatal 
stress can be mimicked in rat models by exposing pregnant dams in their third trimester to various 
forms of stressors (112). Examples of stressors for pregnant rats range from food deprivation, foot-
shock, rodent restrainers to more invasive methods such as exogenous glucocorticoid injection (112). 
Restraint is the most popular form of stressor used in research as it can be easily adapted, and is one of 
the few methods that also directly stress the foetus by limiting its movement (115, 130). 
ANIMAL MODELS AND WHY WE USE THEM 
In order to fully investigate the potential consequences of febrile seizures, the human condition is 
mimicked using animal models, the most commonly used being Sprague-Dawley or Wistar rats (10, 14, 
118, 131, 132). According to the Foundation for Biomedical Research (FBR, 2018)(133), mice and rats are 
used for 95% of all laboratory animal research (133). This is due to their similar human resemblance, 
and their convenient housing due to their small size. Rodents reproduce quickly and have a short 
lifespan allowing several generations to be observed in a relatively short period of time. According to 
the National Human Genome Research Institute (NHGRI, 2018, genome.gov), mice and rats that are 
used in medical trials are usually inbred, allowing them to be almost genetically identical, making the 
results uniform. Rodents genetic, biological and behavioural characteristics closely resemble those of 
humans, thus allowing many human conditions to be replicated for study. 
ANIMAL MODELS OF FEBRILE SEIZURE 
Various methods have been employed to mimic the conditions of febrile seizures, ranging from 
administration of numerous drugs, electrical stimulation, and heated environments (10, 14, 118, 131, 134, 135). 
In order to correctly mimic febrile seizures, two disease states need to be simulated, i.e. a fever, 
followed by seizure activity, expressed as convulsions. Lipopolysaccharide (LPS), the major 
component of the outer wall membrane of Gram-negative bacteria functions to increase the structural 
integrity of the bacteria and to protect the membrane by increasing the negative charge of the cell 
therefore stabilizing the overall membrane structure (136). 
LPS induces a strong defensive response from animal immune systems, thus injecting small amounts 
can mimic a systemic infection, leading to a fever-like situation (10, 14, 131, 136, 137). LPS is easily 
obtainable, inexpensive, easy to work with, and systemic injection triggers the release of 
proinflammatory cytokines such as tumour necrosis factor alpha (TNF-α), IL-6 and IL-1β and is thus 
the most commonly used method to mimic infection and fever in rodent models (8, 12, 136). LPS induces 
fever by triggering COX-2 which catalyses the conversion of arachidonic acid to PGE2, thereby 
causing the increase in the set point temperature (8, 67). It has been shown that systemic injection of LPS 
primes the brain to respond more rapidly to further insult thus producing more severe seizures (137). 
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For this study we used varying doses of LPS in conjunction with a chemoconvulsant to induce febrile 
seizure in young rats. Our model was based on the Heida et al. (2005) model whereby febrile seizures 
were induced in 14-day old rats with a combination of LPS and kainic acid (KA) (138). KA is an 
excitotoxic, convulsive neurochemical and potent neurotoxin derived from the algae Digenea simplex 
that causes immobility, an increased incidence of wet dog shakes, as well as long-lasting generalized 
tonic-clonic convulsions (139). KA produces tissue damage and lesions that are consistent with those 
observed in human patients with temporal lobe epilepsy (140). KA is thus used to mimic seizures 
experienced by children suffering from febrile seizures (10, 14, 118, 131). Intraperitoneal (i.p.) injection of 
KA, a natural analogue to glutamate (141) has been shown to induce febrile seizures by inducing a 
glutamate/GABA imbalance by comprise the ionotropic glutamate receptors (142, 143). KA binds to 
activated kainic acid receptors (KAR), which have been shown to have a high affinity for glutamate 
(141), acting as a specific high affinity agonist (140, 141, 144), therefore increasing glutamate binding and 
evoking seizures (141, 142, 145). Structural changes to glutamate receptors can affect their calcium 
permeability, which can lead to accelerated calcium entry into cells, thereby accelerating 
mitochondrial damage and ultimately cell death (146, 147). 
 
Heida et al. (2005) obtained febrile seizures in at least 50% of animals without recurrent seizures using 
200μg/kg of LPS followed 2 h 30 min later by 1.75mg/kg of KA administered intraperitoneally (2). 
This model proved clinically significant with regards to fever, and seizure duration of at least 60 
minutes and is therefore considered a favourable model in many research laboratories (10). Previous 
work done in our laboratory using this model however induced febrile seizures in 100% of animals 
treated, with many of our animals experienced reoccurring severe tonic-clonic convulsions with a high 
mortality rate, making its use daunting to students. 
 
Extended exposure to a hyperthermic environment (H) can adversely affect brain health, body 
performance and comfort, and in extreme cases can lead to death (148). Prolonged febrile seizures have 
been be initiated by maintaining a core temperature of 38.5-42.5 ºC for approximately 30 minutes (149-
151). Core temperatures of 38.5 to 42.5 ºC corresponds to threshold temperatures that would be required 
to evoke complex febrile seizures in human neonates (149-151). Holtzman et al. (1981) (152) made use of a 
heated chamber, Hjeresen et al. (1983) (153) made use of a microwave, Dubé et al. (2000) (154), Koyama 
et al. (2012) (132) and Tao et al. (2016) (155) made use of a hair dryer, whereas Jiang et al. (1999) (156) 
and Yagoubi et al. (2015) (149) made use of a hot water bath. 
Briefly, in each case young rats ranging from 10 to 15 days old were placed in heated environments 
for a brief period to increase core body temperature. In each case, as soon as signs of seizure occurred, 
the rats were removed from the hyperthermic environment and observed for seizure activity (132, 149, 152, 
154). The pups were then returned to their dams once seizures ceased and body temperatures returned to 
normal (132, 149, 152, 154). Seizures induced in rats by H are usually more subtle than those induced by 
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chemoconvulsants, but are identifiable through behavioural symptoms such as sudden arrest of 
hyperthermia-induced hyperactivity, facial automatism, forelimb clonus and tonic body flexion (157, 158). 
 
AIMS AND OBJECTIVES 
For this study we mimicked febrile seizures on postnatal day (PND) 14 Sprague Dawley pups using 
models established by Heida et al. (2005) (2), and a novel model to our laboratory by Yagoubi et al. 
(2015) (149). The Heida et al. (2005) model of LPS and KA was selected for its accuracy in mimicking 
both the fever and the convulsions in a similar manner experienced by young children, however it 
yielded a high mortality rate. The aim of this study was thus to refine the current model by lowering 
the dose of both LPS and KA in an attempt to lower the high mortality rate experienced with this 
model, all while maintaining successful seizure outcomes. A second goal of this study was to 
introduce and optimise an alternate less invasive febrile seizure model, a hyperthermic model by 
Yagoubi et al. (2015) (149) for use in our laboratory. 
 
The focus of this study was thus to investigate: 
 
1. Determine the most effective and efficient dose of LPS and KA to induce febrile seizures in 
rats, while maintaining a high survival rate. 
2. Determine the most effective and efficient LPS-KA and hyperthermia-based animal models of 
febrile seizure to be used in our laboratory. 
3. Assess the neurochemical effect of prenatal stress on PGE2 and its receptor EP3R 
concentration in hypothalamic tissue of LPS-KA and hyperthermia based animal models of 
febrile seizure. 
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HIGHLIGHTS 
• A lowered dose of LPS (50 µg/kg) and KA (0.44 mg/kg), was capable of inducing seizures 
while maintaining a high survival rate. 
• All rat pups exposed to a heated environment for a period of time experienced mild to 
moderate seizures, ranging from facial twitching to jerking and loss of posture. 
• Prenatal stress lead to a decreased expression of PGE2 in the hypothalamus of febrile seizure 
animals. 
• Prenatal stress increased seizure severity, and hypothalamic EP3R concentrations. 
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ABSTRACT 
Background: Febrile seizures are the most common type of seizure experienced by 3 months to 6-
year-old children. Proinflammatory cytokines, often triggered by simple infections, are known 
mediators of fever, and have been implicated in febrile seizure onset. Of particular interest is the 
mechanism involving fever through prostaglandin E2 (PGE2) production, and prenatal stress which is 
prominent in third world countries, and has been shown to exacerbate febrile seizures in offspring. 
Animal models mimicking febrile seizures can result in 50% seizure onset or yield high mortality 
rates, therefore the aim of this study was to refine two existing models of febrile seizure to yield 
greater % of seizure onset with low mortality. 
 
New method: Pregnant Sprague Dawley dams were exposed to prenatal stress, and febrile seizures 
induced in their subsequent offspring on postnatal day 14 by one of two refined models. We refined 
the Heida et al. (2005) 200 µg/kg lipopolysaccharide (LPS) and 1.75 mg/kg kainic acid (KA) model 
and adapted a novel hyperthermic (H) model for use in our laboratory. 
 
Results: Dosage was reduced to 50 µg/kg LPS and 0.44 mg/kg KA which significantly decreased 
mortality, while yielding 100% convulsions. The adapted H model produced 100% successful 
convulsions. Additionally, exposure to prenatal restraint stress significantly exacerbated seizure 
severity. 
 
Comparison with Existing Method(s): The modified LPS-KA and H models successfully induced 
convulsions with drastically reduced mortality rates compared to existing models. 
 
Conclusion: The modified LPS-KA model was selected as the most effective and most efficient 
model. 
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1 INTRODUCTION 
A febrile seizure is a neurological abnormality that presents with neuronal hyper-excitability and 
convulsions, usually occurring after a fever due to an underlying systemic infection i.e. gastrointestinal 
and upper respiratory tract infections, or middle ear infections (1-3). Triggered by these infections, 
febrile seizures are thought to be linked to the activation of the immune system through the release of 
pro-inflammatory cytokines, predominantly interleukin-1 beta (IL-1β), interleukin 6 and tumour-
necrosis factor alpha (4-7). The increased IL-1β influx triggers the enzyme cyclooxygenase-2, which 
catalyses the conversion of arachidonic acid into prostaglandin E2 (PGE2), that subsequently triggers 
the preoptic nuclei region of the hypothalamus to increases core body temperature (8-15). In order to 
induce fever, PGE2 acts on prostaglandin EP3 receptors (EP3R) predominantly in the medial and 
median preoptic nuclei regions of the hypothalamus (16-18). The exact mechanism by which PGE2 is 
synthesised is not well understood, but it is evident than many prostaglandin products act in 
conjunction with cyclooxygenases to produce target prostaglandins (2, 11, 12, 19, 20). 
 
Various animal models have been developed to mimic the conditions of febrile seizures, ranging from 
the administration of drugs, electrical stimulation, or heated environments (3, 21-25). One of the drug 
induced febrile seizures models is the Heida et al. (2005) (26) injection of gram negative bacterial 
endotoxin lipopolysaccharide (LPS) (200 μg/kg) followed 2 h 30 min later by a sublethal dose of 
kainic acid (KA) (1.75 mg/kg) (26). Holtzman et al. (1981) (27) made use of a heated chamber, Hjeresen 
et al. (1983) (28) made use of a microwave, Dubé et al. (2000) (29), Tao et al. (2016) (30) and Koyama et 
al. (2017) (31) made use of a hair dryer, whereas Jiang et al. (1999) (32) and Yagoubi et al. (2015) (33) 
made use of a hot water bath. Briefly in each case, young rats ranging from 10 to 15 days old were 
placed in heated environments for a brief period to increase core body temperature. In all cases, as 
soon as signs of seizure occurred, the rat pups were removed from the heated environment, and 
observed for seizure activity (27, 29, 31, 33). Furthermore, exposure to prenatal stress during the last 
trimester has been shown in our laboratory by Qulu et al. (2012) (3) to exacerbate febrile seizures in rat 
offspring through dysregulation of the offspring’s hypothalamic-pituitary-adrenal axis (3, 23, 34). 
 
Previous work done in our laboratory by Qulu et al. (2012; 2015) (3, 22), Cassim et al. (2015) (23), and 
Mkhize et al. (2017) (35) using the Heida et al. (2005) (26) model induced febrile seizures in 100% of 
animals treated, in contrast to at least 50% experienced by the Heida et al. (2005), and had a high 
mortality rate, especially when coupled with prenatal stress (3, 22, 23, 35, 36). Prenatal stress has been 
shown to result in the dysregulation of the foetal HPA axis, thus allowing increased entry and 
exposure of the foetus to maternal cortisol (37). Cortisol in excess results in an increased 
proinflammatory response, leaving the new-born more prone to infection than non-prenatally stressed 
neonates (38-43). Many of our animals experienced reoccurring severe tonic-clonic convulsions with a 
25 
 
high mortality rate. The model itself however has proven to be of vital importance in studying febrile 
seizures due the accurate portrayal of the disorder, i.e. fever due to proinflammatory cytokine release, 
followed by neuronal hyperexcitability (3, 22, 23, 26, 35, 36, 44, 45). However, to effectively reduce the 
mortality rate associated with this model, the aim of our study was to investigate the most effective 
and efficient dose of LPS and KA to induce febrile seizures, while maintaining a high survival rate. 
We also aimed to introduce and refine a new model based on work done by Jiang et al. (1999) (32) and 
Yagoubi et al. (2015) (33), and thus set out to determine the most effective and efficient febrile seizure 
rat model to use in our laboratory. As with our previous studies, febrile seizures were induced in 14-
day old Sprague Dawley rat pups. 
2 MATERIALS AND METHODS  
2.1 MATERIALS 
Lipopolysaccharide (LPS) (Escherichia coli O111:B4 phenol extraction, lyophilized powder) and 
kainic acid (KA) (kainic acid monohydrate K0250, dry powder) were obtained from Sigma-Aldrich, 
(Gauteng, South Africa). Both drugs were dissolved in saline solution (0.9 %; 10 ml/kg) and injected 
intraperitoneally (i.p.) using a 29 G 0.5 mm insulin needle. Elabscience ELISA kits were obtained 
from Anatech, Gauteng, South Africa. The Zymo Research Quick-RNA™ Miniprep Kit RNA 
extraction kit was obtained from Inqaba Biotechnical Industries, Pretoria, South Africa. The iScript™ 
cDNA synthesis kit and the iTaq™ universal SYBR Green Supermix, both from Bio-Rad were 
obtained from Lasec, Cape Town, South Africa. 
2.2 BREEDING ANIMALS 
All procedures were performed under ethical clearance (AREC/045/018M) from the University of 
KwaZulu-Natal Research Committee, Animal Ethics sub-committee. A total of 15 female and 5 male 
Sprague Dawley (SD) rats were obtained from the Biomedical Resource Unit of the University of 
KwaZulu-Natal, (6 females for the preliminary toxicity study, and 8 females for the rat model 
comparison study), a total of 72 pups were used. Rats were group housed under standard laboratory 
conditions of 22±1°C room temperature, 70 % humidity, and a 12 h light/dark cycle (lights on at 06:00 
h, off at 18:00 h). Food and water were available ad libitum. 
2.3 MATING AND PRENATAL STRESS PROTOCOL 
Female SD rats were paired and allowed a week to acclimatise to minimise stress, and synchronise 
oestrous cycles. Thereafter, vaginal smears were done daily to assess the female’s oestrus cycle, and a 
male rat introduced during proestrus for mating (46). Vaginal smears were performed to determine 
successful mating through the presence of sperm in the smear, after which the male rat was removed 
(46). On gestational day (GND) 14, pregnant females were divided into 2 groups, non-stressed (NS) left 
undisturbed in their home cages, and stressed (S). To induce stress, female dams were taken daily to a 
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separate room and placed in rodent restrainers for 1 h a day, for a total of 7 days (3, 22). All stress 
procedures were carried out between 11:00 h and 12:00 h. The S pregnant rats were returned to their 
home cages at the end of the stress period each day. 
2.4 STUDY A: PRELIMINARY DOSE OPTIMIZATION 
In this study we compared different dose of LPS and KA to effectively induce febrile seizures, while 
maintaining a high survival rate. 
2.4.1 POSTNATAL HANDLING 
On postnatal day (PND) 14, at 10:00 h, the NS and S pups were removed from their dams and 
separated into 5 groups as shown in Table 2.1 (n = 3/group). To induce febrile seizures the Heida et al. 
(2005) (26) model was modified; each group was injected i.p. with a step-wise reduced percentage of 
the total dose of LPS (200 µg/kg) followed 2 h 30 min later by the same step-wise reduced percentage 
of the total dose of KA (1.75 mg/kg) to induce febrile seizures. LPS and KA were both dissolved in 
saline solution (0.9 %; 10 ml/kg) and injected i.p. The controls were injected with saline twice in the 
same manner as the experimental groups to account for injection stress. 
Table 2.1 Study A. Reduced LPS and KA doses. n=3/group. 
 
2.4.2 BEHAVIOURAL ANALYSIS 
2.4.2.1 ASSESSMENT OF TEMPERATURE 
Oral temperature (ºC) was measured with a Medic Thermometer Digital Flexi Tip (110442000EA, 
Dis-Chem, South Africa) at least 15 min after removing pups from their dams in order to minimise an 
increased reading due to feeding. Recordings were taken for each pup prior to the first injection, and 
then again 15 min after the second injection. 
2.4.2.2 ASSESSMENT OF FEBRILE SEIZURE SEVERITY 
Febrile seizures were video recorded and assessed for 1h 30 min after the injection of KA, the footage 
was loaded onto the behavioural analysis programme BORIS (47) (version 6.3.5) and the behaviour 
 Non-Stressed Stressed 
1. Control Saline 10 ml/kg Saline 10 ml/kg Saline 10 ml/kg Saline 10 ml/kg 
2. 25% LPS 50 µg/kg KA 0.44 mg/kg LPS 50 µg/kg KA 0.44 mg/kg 
3. 50% LPS 100 µg/kg KA 0.88 mg/kg LPS 100 µg/kg KA 0.88 mg/kg 
4. 75% LPS 150 µg/kg KA 1.31 mg/kg LPS 150 µg/kg KA 1.31 mg/kg 
5. 100%  LPS 200 µg/kg KA 1.75 mg/kg LPS 200 µg/kg KA 1.75 mg/kg 
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rated by third party candidates blinded to the treatments. The behaviour was scored a severity rate of 0 
– no response, to 5 – repeated severe tonic-clonic convulsions on the Racine scale shown in Table 2.2. 
Table 2.2 Seizure severity was assessed using the following Racine scale (3, 5, 48). 
Stage Behavioural Response 
0 No response 
1 Ear and facial twitching 
2 Loss of postural control 
3 Myoclonic jerks and rearing 
4 Clonic convulsions – animal falling on its side 
5 Repeated severe tonic-clonic convulsions 
 
2.4.3 TISSUE COLLECTION AND ANALYSIS 
On PND 16, at 10:00 h, a sharp guillotine was used to decapitate the rat pups. Hypothalamic tissue 
was collected in 1.5 ml nuclease-free Eppendorf tubes, snap frozen in liquid nitrogen and then stored 
in a bio freezer at -80 °C for further analysis. 
2.4.3.1 PROSTAGLANDIN E2 (PGE2) CONCENTRATION ANALYSIS 
PGE2 concentrations were assessed in hypothalamic tissue by means of competitive enzyme-linked 
immunosorbent assay (ELISA). The ELISA was performed using the Elabscience PGE2 
(Prostaglandin E2) ELISA Kit (E-EL-0034) (Elabscience, Wuhan, China) according to the 
manufactures guidelines. In short, frozen samples were thawed on ice, diluted (1:9) in ice-cold 
phosphate-buffered saline (PBS) (pH 7.4) and homogenised on ice using a sonicator (Qsonica, 
MODEL CML-4), centrifuged (Hermle LASEC, Germany) at 5000 x g and the supernatant collected 
for the assay. The assay procedure was performed in duplicate for each standard and each sample 
following the manufactures guidelines. The plate was washed using a BioTek ELx50 plate washer 
(BioTek, Highland Park, USA), incubated at 37°C, and optical density (OD) read at 450 nm in a 
SPECTROstar Nano (BMG, Labtech Ortenberg, Germany) absorbance plate reader. 
2.4.3.1.1 Calculations 
The average (avg.) OD was calculated for each standard and sample, then correct by subtracting the 
avg. blank (B) OD value as in Equation 2.4.3.1. 
Equation 2.4.3.1  𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 𝑂𝐷 𝑣𝑎𝑙𝑢𝑒 =  𝑎𝑣𝑔. 𝑂𝐷 − 𝑎𝑣𝑔. 𝐵 𝑂𝐷 
The corrected standard OD values were inserted into Graph Pad Prism version 7 (GraphPad Software 
Inc., California, USA) to obtain a linear regression graph. The X values of the linear regression graph 
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were used to interpolate sample concentrations. The concentrations were subjected to column statistics 
to determine the distribution, and thereafter further analysed to determine statistical significance. 
2.5 STUDY B: EFFECTS OF PRENATAL STRESS ON RAT MODELS OF FEBRILE SEIZURE 
In this study we compared the effectiveness of two febrile seizure models. A preselected dose 
established from the preliminary dose study was used for the drug induced model, and a hyperthermic 
model adapted for use in our laboratory. 
2.5.1 PRENATAL HANDLING 
Pregnant Sprague Dawley rats were separated into non-stressed (NS) and stressed (S) groups, prenatal 
stress was induced on GND 14 using the method described in study A section 0. 
2.5.2 POSTNATAL HANDLING 
On PND 14, at 10:00 h, the NS and S pups were removed from their dams and separated into 3 groups 
(n = 7/group). Pups received either a combination LPS and KA, or they were exposed to a heated 
environment to induce febrile seizures. Control animals were injected i.p. with saline, in the same 
manner as the LPS-KA animals to account for injection stress. 
2.5.2.1 LPS-KA MODEL 
The preselected dose of LPS and KA from study A was used to induce febrile seizures in study B, i.e. 
50 µg/kg of LPS dissolved in saline solution (0.9%; 10 ml/kg) injected i.p., followed 2h 30 min later 
by a second i.p. injection of 0.44 mg/kg KA, dissolved in saline solution (0.9%; 10 ml/kg). The change 
in oral temperature and seizure severity was assessed in the same manner as described in Study A, 
section 2.4.2 Seizure progression was scored using the Racine scale in Table 2.2 above. 
2.5.2.2 HYPERTHERMIC MODEL 
The hyperthermic environment (H) model, based on previous models by Jiang et al. (1999) (32) and 
Yagoubi et al. (2015) (33), was refined to make it suitable for use in our laboratory. A well ventilated 
clear hard plastic (polypropylene) 350 ml container was used to house the rat pup, in place of a glass 
container. Ventilation was achieved through small holes drilled into the container lid, as well as the 
upper rim of the container, as a ventilated lid alone proved to be insufficient. The bottom of the plastic 
container was lined with 2 cm thick polystyrene, which conducted little heat, thus prevented the pup’s 
paws from burning. The container with the pup (n = 1/container) securely enclosed was submerged 
into a water bath maintained at 60 °C ± 1 °C for about 20 min to allow for a rise in their core 
temperature. Care was taken to ensure no water entered the container. Once a myoclonic jerk, was 
experienced, the pup was removed from the container and oral temperature measured before 
transferring the pup back to room temperature, where it was assessed and scored for further 
convulsions. Pups were cooled with cold water, rehydrated, dried off, then returned to their home 
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cage. Containers were well cleaned with 70% ethanol after each test. Pups removed from the heated 
environment before stage 3 myoclonic jerks failed to display further seizure activity. 
2.5.3 TISSUE COLLECTION AND ANALYSIS 
A sharp guillotine was used to decapitate the rat pups on PND 16, at 10:00 h. Hypothalamic tissue was 
collected in 1.5 ml nuclease-free Eppendorf tubes, snap frozen in liquid nitrogen and stored in a bio 
freezer at -80 °C for further analysis. 
2.5.3.1 PROSTAGLANDIN E2 (PGE2) CONCENTRATION ANALYSIS 
PGE2 concentrations were assessed in hypothalamic tissue by ELISA in the same manner as described 
in Study A, section 2.4.3.1. The ELISA was performed using the Elabscience PGE2 (Prostaglandin E2) 
ELISA Kit (E-EL-0034) (Elabscience, Wuhan, China) according to the manufactures guidelines. The 
same calculations described in Study A, section 2.4.3.1.1 were used in order to calculate the sample 
PGE2 concentrations. 
2.5.3.2 PROSTAGLANDIN E2 RECEPTOR (EP3R) CONCENTRATION 
Prostaglandin EP3 receptor (EP3R) expression was quantified in hypothalamic tissue by means of 
Real-Time Polymerase chain reaction (qPCR). Primers for the target gene EP3R and the reference gene 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were designed on Primer-BLAST (sequence 
shown in Table 2.3), and were obtained from Inqaba Biotechnical Industries (Pty) Ltd. Primers were 
diluted to a 100mM stock solution by adding nuclease-free water as per manufacturer instructions. 
Table 2.2 Study B. PCR Target and Reference primers. Primers were selected to be 20 base pairs long, falling 
within the 18-22 base MIQE suggested length. Primers were chosen to have similar melting temperatures 
between 55-60 ºC, and minimal primer dimer formation opportunities (49). 
Primer Forward Reverse NCIB number 
EP3R ATACCTGCTTCCCTGAGTAT GAGGCCGAAAGAAGATACAA NM_012704.1 
GAPDH AGTGCCAGCCTCGTCTCATA GATGGTGATGGGTTTCCCGT NM_017008.4 
 
The qPCR analysis was carried out in accordance to the corresponding manufactures guidelines for the 
3 major steps, i.e. 1.) RNA isolation using the Zymo Research Quick-RNA™ Miniprep Kit 
(ZAR1054), 2.) cDNA synthesis using the Bio-Rad iScript™ cDNA Synthesis Kit (1708891), and 3.) 
amplification using the Roche iTaq™ Universal SYBR Green Supermix (1725120). To isolate RNA, 
samples were thawed and homogenized (Qsonica, MODEL CML-4) on ice, and then purified with an 
in-column DNase I treatment to remove all trace DNA. Eluted RNA concentrations were measured for 
purity using a Nanodrop 2000 (Thermo Scientific, Roche, South Africa). A purity ratio (A260/A280) 
of 1.7 – 2.1 was considered sufficient for conversion to cDNA. RNA was diluted with nuclease-free 
water to 50 ng/µl and converted to cDNA in a thermocycler 2.0 (Roche, South Africa) on the same 
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day in white 8-strip clear capped PCR tubes (Whitehead Scientific, Cape Town, South Africa) then 
stored at -20 °C to be used for amplification the following day. 
For amplification , the target and reference primer stock solutions were diluted 1:20 to form the 
working dilution (50 ng/ul) for amplification. The reaction mix was prepared in accordance with the 
Roche SYBR Green Supermix and run in duplicate in a Roche LightCycler96 (Roche, South Africa). 
The reaction mixture and amplification procedures were carried out in white 8-strip clear capped PCR 
tubes (Whitehead Scientific, Cape Town, South Africa). 
2.5.3.2.1 Calculations 
Gene fold expression of EP3R relative to the reference GAPDH was calculated using the 2-(∆∆Cq) 
method (49). The avg. quantification cycle (Cq) values were calculated for each sample containing the 
target gene (EP3R), and for the same samples containing the reference gene (GAPDH). The change in 
Cq for each sample including the controls were then calculated by subtracting the reference avg. Cq 
from the target avg. Cq, as shown in Equation 2.5.3.2. The avg. double change in Cq value was then 
calculated by subtracting the Cq change of the control samples from the Cq change of the 
experimental samples as shown in Equation 2.5.3.2. The double change values calculated in Equation 
2.5.3.2 were then put to the negative power of 2 in order to calculate the fold change 2-(∆∆Cq) values 
used for further statistical analysis, as shown in Equation 2.5.3.2 (49). 
Equation 2.5.3.2  𝑎𝑣𝑔. ∆𝐶𝑞 = 𝑡𝑎𝑟𝑔𝑒𝑡 𝑎𝑣𝑔. 𝐶𝑞 − 𝑟𝑒𝑓𝑟𝑒𝑛𝑐𝑒 𝑎𝑣𝑔. 𝐶𝑞 
Equation 2.5.3.2  𝑎𝑣𝑔. ∆∆𝐶𝑞 = 𝑠𝑎𝑚𝑝𝑙𝑒 𝑎𝑣𝑔. ∆𝐶𝑞 − 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝑎𝑣𝑔. ∆𝐶𝑞 
Equation 2.5.3.2  2−(∆∆𝐶𝑞) = 2−(Equation 2.5.3.2) 
The 2^-(∆∆Cq) values were inserted into Graph Pad Prism version 7 (GraphPad Software Inc., California, 
USA). The data were subjected to column statistics to determine distribution, and thereafter further 
analysed to determine statistical significance. For the target EP3R standard curve: y = -3.4488; y-int = 
32.66; R2 = 0.99; efficiency = 1.95. For the reference GAPDH standard curve: y = -3.5338; y-int = 
27.08; R2 = 0.88; efficiency =1.92. 
2.6 DATA ANALYSIS 
All datasets were analysed using the statistical software programme Graph Pad Prism version 7 
(GraphPad Software Inc., California, USA). Gaussian distributions were determined using the 
Shapiro-Wilk normality test on all data sets before further analyses. Where Gaussian distributions 
were evident, parametric two-way analysis of variance (ANOVA) tests were performed, followed by 
Tukey-Kramer post hoc tests. Seizure severity and survival rate data were analysed by Kruskal-Wallis 
tests followed by Dunn’s multiple comparisons test. Correlation tests were performed where stated, 
and significant p values, and Pearson correlation r values reported. An n = 3 animals were assessed per 
group for Study A, and an n = 7 animals were assessed per group for study B. P < 0.05 was considered 
statistically significant. Data are presented as mean values, with standard error of the mean (SEM). 
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3 RESULTS 
3.1 STUDY A: PRELIMINARY DOSE OPTIMIZATION 
To assess an effective dose of lipopolysaccharide (LPS) and kainic acid (KA) for febrile seizure 
induction, a dose assessment test was conducted for non-stressed (NS) and stressed (S) PND 14 rat 
pups receiving varying doses of LPS and KA, e.g. 25% - 100% of the original dose (LPS 200 µg/kg, 
KA 1.75 mg/kg). The following 5 groups were assessed: (NS-C; S-C), (NS-25%; S-25%), (NS-50%; 
S-50%), (NS-75%; S-75%), and (NS-100%; S-100%). The average change in temperature, seizure 
severity and survival for each group was analysed for statistical significance. 
3.1.1 TEMPERATURE AND SEIZURE SEVERITY OF FEBRILE SEIZURE DOSAGE GROUPS 
An overall dose-dependent decrease in oral temperature (F(4, 20) = 19.84; p < 0.0001), as well as an 
overall dose-dependent increase of seizure severity (F(4, 20) = 71.83; p < 0.0001) was observed. Overall, 
a greater drop in oral temperature significantly correlated with an increase in seizure severity for both 
the NS pups (NS temperature vs NS seizure severity p = -0.0074; r = -0.966) and the S pups (S 
temperature vs S seizure severity p= -0.0259; r = -0.922). A greater overall change in temperature 
occurred for the 100% dose when compared to the 25% dose, who experienced smaller changes in 
temperature.  
A dose effect was observed as the NS-25% pups experienced facial twitching with loss of postural 
control which was significantly less severe than the NS-100% pups that experienced clonic 
convulsions with many pups falling on their side (NS-25% vs NS-100% p = 0.0014). 
A significant overall stress effect on seizure severity was observed (F(1, 20) = 5.444; p = 0.0302), as all 
S pups experienced more severe seizures when compared to their NS counterparts, i.e. on average the 
S-25% pups experienced myoclonic jerks coupled with loss of postural control, whereas the S-100% 
pups all reached stage 5 repeated severe tonic-clonic convulsions (S-25% vs S-100% p = 0.0342). As 
dosage was increased, temperatures dropped significantly, which correlated with more severe seizures, 
which often resulted in the death of the animal. Data presented as mean ± SEM in Figure 3.1 
 Stressed 
 Change in 
oral 
Temperature 
Average 
Seizure 
Severity 
Change in 
oral 
Temperature 
Average 
Seizure 
Severity 
Control -0.73°C 0.00 -0.60°C 0.00 
25% -2.97°C 2.33 -2.50°C 3.33 
50% -3.43°C  3.33 -3.10°C 3.67 
75% -3.27°C 4.00 -2.63°C 4.67 
100% -4.47°C 4.67 -4.17°C 5.00 
Study A: Preliminary Toxicity Test Behavioural Results. Change in Oral Temperature, Seizure Severity and 
Survival. Initial and post treatment oral temperature was measured for each pup, thereafter seizers were scored 0 
– no response, to 5 – repeated severe tonic-clonic convulsions on a Racine scale. Survival was regarded as 
surviving until sacrifice. n = 3/group. 
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Preliminary Dose Test: Correlation between Oral Temperature and Seizure Severity. 
 
Figure 3.1 Study A: Graph depicting change in oral temperature and seizure severity of NS and S animals 
receiving different doses of LPS-KA. A high correlation was evident for NS (NS temperature vs NS seizure 
severity p = 0.0074; r = -0.966), and S pups (S temperature vs S seizure severity p = 0.0259; r = -0.922). I p < 
0.05 compared to NS-100%. II p < 0.05 compared to S-100%. Data presented as mean ± SEM in each group. n = 
3/group. 
3.1.2 PUP SURVIVAL IN DIFFERENT FEBRILE SEIZURE DOSAGE GROUPS 
Mortality was measured in NS and S rat pups exposed to varying doses of LPS and KA by recording 
their survival rate. No deaths occurred in control groups. The overall survival rate of the pups was 
shown to be significantly dose-dependent (F(4, 20) = 3.583; p = 0.0233). The NS-25% pups showed the 
highest survival rate, and a Dunn’s multiple comparisons test showed that the NS-25% pups had a 
significantly higher survival rate than the NS-100% pups, (NS-25% vs NS-100% p = 0.0151). Data 
presented as mean ± SEM in Figure 3.2. 
Preliminary Dose Test: Pup Survival Rate. 
 
Figure 3.2 Study A: Graph depicting percentage survival for NS and S animals receiving different doses of LPS-
KA. # p < 0.05 compared to NS-C & NS-25%. Data presented as mean ± SEM in each group. n = 3/group. 
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3.1.3 PROSTAGLANDIN E2 (PGE2) CONCENTRATIONS AT DIFFERENT DOSES OF LPS-KA 
PGE2 concentrations were measured in hypothalamic tissue of the surviving NS and S rat pups treated 
with the different doses of LPS and KA. The 100% dose was excluded due to the high mortality rate. 
Overall PGE2 concentrations were significantly dose-dependent (F(3, 14) = 6.575; p = 0.0053), most 
prominent within the NS pups, i.e. (NS-C vs NS-50% p = 0.0128), (NS-C vs NS-75% p < 0.0001). 
The lower 25% dose, was as effective as the higher 50% dose in inducing an upregulation in PGE2 
concentration in NS rats, but significantly less effective than the 75% dose i.e. (NS-25% vs NS-75% p 
= 0.0047), (S-25% vs S-75% p = 0.0008). Overall, a significant stress-induced decrease in PGE2 
concentrations was observed (F(1, 14) = 47.73; p < 0.0001). There was also a significant interaction 
between stress and the dose of LPS-KA (F(3, 14) = 15.40; p < 0.0001). Hypothalamic PGE2 
concentrations increased with increasing dose of LPS-KA in NS pups but decreased in S pups. Data 
presented as mean ± SEM in Figure 3.3 
Preliminary Dose Test: PGE2 Concentration. 
 
Figure 3.3 Study A: Graph depicting PGE2 concentration for NS and S animals receiving different doses of LPS-
KA. # p < 0.05 compared to NS-C. I p < 0.05 compared to NS-75%. II p < 0.05 compared to S-75%. Data 
presented as mean ± SEM in each group. n = 3/group, -1 animal for the S-50% and S-75%. 
3.2 STUDY B: EFFECTS OF PRENATAL STRESS ON RAT MODELS OF FEBRILE SEIZURE 
After selecting the appropriate dose of LPS-KA to induce febrile seizures, we determined the most 
efficient and effective febrile seizure rat model to use in our laboratory. NS and S PND 14 rat pups 
received either the selected 25% dose of LPS and KA, or they were exposed to a hyperthermic (H) 
environment to induce febrile seizures. The following 3 groups were assessed: (NS-C; S-C), (NS-LPS-
KA; S-LPS-KA), and (NS-H; S-H). The average change in temperature, seizure severity and 
percentage survival rate for each group was analysed for statistical significance. 
  
Control 25% 50% 75%
0
200
400
600
800
1000
1200
Experimental Groups
P
G
E
2
 C
o
n
c
e
n
tr
a
ti
o
n
 p
g
/m
L
Tox ELISA
Non-Stressed
Stressed
#
#
I
II
34 
 
3.2.1 ASSESSMENT OF ORAL TEMPERATURE OF RAT MODELS OF FEBRILE SEIZURE 
Fever progression was assessed by measuring oral temperature in NS and S rat pups exposed to either, 
LPS-KA or H. Both models elicited significant overall changes in oral temperature (F(2, 36) = 256.5; p < 
0.0001), with the NS-LPS-KA animals exhibiting a drop in oral temperature (NS-C vs NS-LPS-KA p 
< 0.0001), while H groups exhibited increased temperatures, i.e. (NS-C vs NS-H p < 0.0001), (S-C vs 
S-H p < 0.0001). Post hoc tests revealed a significant difference between the two models, i.e. (NS-
LPS-KA vs. NS-H p < 0.001) and (S-LPS-KA vs. S-H p < 0.001). Both models were also significantly 
affected by stress (F(1, 36) = 28.28; p = 0.0001), that was most evident in LPS-KA treated animals (NS-
LPS-KA vs S-LPS-KA p < 0.0001). Data presented as mean ± SEM in Figure 3.4 
Rat Models of Febrile Seizure: Change in Oral Temperature. 
 
Figure 3.4 Study B: Graph depicting change in oral temperature for NS and S animals undergoing either LPS-
KA or H induced febrile seizures. # p < 0.05 compared to NS-C. * p < 0.05 compared to S-C. I p < 0.05 
compared to NS-H. II p < 0.05 compared to S-H. Data presented as mean ± SEM in each group. n = 7/group. 
3.2.2 ASSESSMENT OF SEIZURE SEVERITY IN RAT MODELS OF FEBRILE SEIZURE 
A Kruskal-Wallis and Dunn’s multiple comparisons test showed both models were equally efficient in 
inducing seizures, i.e. the NS-LPS-KA pups experienced myoclonic jerks with many pups rearing and 
falling on their side, while the NS-H pups experienced mild myoclonic jerks with loss of postural 
control. In order to determine the effect of prenatal stress, the data of the pups in the seizure groups 
were analysed by two-way ANOVA, since the data were normally distributed. Prenatal stress 
significantly exacerbated seizure severity (F(1, 24) = 8.64; p = 0.0072) for the two models, i.e. the S-
LPS-KA pups experienced tonic-clonic convulsions with some pups falling on their side, while the S-
H pups experienced clonic convulsions. Data presented as mean ± SEM in Figure 3.5 
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Rat Models of Febrile Seizure: Average Seizure Severity. 
 
Figure 3.5 Study B: Graph of average seizure severity assessed for NS and S animals undergoing either LPS-KA 
or H induced febrile seizures. # p < 0.05 compared to NS-C. * p<0.05 compared to S-C. Data presented as mean 
± SEM in each group. n = 7/group. 
3.2.3 PUP SURVIVAL IN RAT MODELS OF FEBRILE SEIZURE 
Mortality was measured in NS and S rat pups exposed to either LPS-KA or H to induce febrile 
seizures. No deaths occurred in NS and S pups for both the control and H groups. A significant overall 
effect of the model on the survival rate of the pups was observed (p < 0.0047). A Dunn’s multiple 
comparison test showed S-LPS-KA pups had a significantly higher mortality when compared to the 
respective control, i.e. (S-C vs S-LPS-KA p = 0.0322), and S-H model, i.e. (S-LPS-KA vs S-H p = 
0.0322). Data presented as mean ± SEM in Figure 3.6. 
Rat Models of Febrile Seizure: Survival Rate. 
 
Figure 3.6 Study B: Graph depicting percentage survival rate assessed for NS and S animals undergoing either 
LPS-KA or H induced febrile seizures. * p < 0.05 compared to S-C. I p < 0.05 compared to S-H. Data presented 
as mean ± SEM in each group. n = 7/group. 
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3.2.4 PGE2 AND RECEPTOR EP3R CONCENTRATIONS BETWEEN RAT MODELS OF FEBRILE SEIZURE 
PGE2 concentrations and receptor EP3R expression were measured in hypothalamic tissue of NS and S 
pups. A two-way ANOVA did not reveal any significant differences in PGE2 concentrations, however 
a significant change was observed in the EP3R gene expression. There was a significant effect of 
seizures (F(2, 12) = 2.369; p = 0.0498) which was mainly due to an increase in EP3R expression in 
prenatally stressed seizure groups, however the overall effect of stress on EP3R expression was not 
statistically significant (F(1, 12) = 3.731; p = 0.0774). Further analysis showed that S pups’ PGE2 
concentrations correlated significantly with their EP3R gene expression i.e. (S PGE2 vs S EP3R p = 
0.0413; r = -0.998). Correlation between the NS pups PGE2 and EP3R were also seen, however this 
was not statistically significant i.e. (NS PGE2 vs NS EP3R p = 0.0709; r = -0.994. Data presented 
together as mean ± SEM in Figure 3.7. 
Rat Models of Febrile Seizure: PGE2 and EP3R Concentration. 
 
Figure 3.7 Study B: Graphs depicting hypothalamic PGE2 concentration and EP3R expression for NS and S 
pups undergoing LPS-KA or H induced febrile seizures. Graph A depicts PGE2 concentration assessed via 
ELISA. Graph B depicts relative EP3R concentration assessed via PCR. Graph C consists of both data sets 
against a Log10 scale. Data presented as mean ± SEM in each group. n = 3/group. 
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4 DISCUSSION 
In this study, we re-examined our current febrile seizure rat model by assessing an alternative dose, as 
well as an alternative model to induce febrile seizure like symptoms in rat pups. The Heida et al. 
(2005) (26) lipopolysaccharide (LPS) and kainic acid (KA) model has successfully played a major role 
in inducing febrile seizures in our laboratory, however the dose has yielded a high mortality rate. 
Therefore, study A aimed to refine our current febrile seizure rat model by assessing an ideal LPS and 
KA (LPS-KA) dose derived from the original Heida et al. (2005) (26) dose. Study B aimed to determine 
the most effective and efficient rat model to mimic febrile seizures i.e. a modified LPS-KA model, or a 
hyperthermic environment (H) model. 
 
Pregnant Sprague Dawley rats were separated into one of two groups in both studies, non-stressed 
(NS) where dams were left undisturbed throughout pregnancy, and stressed (S) where dams were 
exposed to restraint stress for 1 h a day for a total of 7 days in their third trimester. Febrile seizures 
were induced in the subsequent pups on postnatal day (PND) 14. Study A consisted of 5 groups that 
received different percentages of the original Heida et al. (2005) (26) dose including a control (C): (NS-
C; S-C); (NS-25%; S-25%); (NS-50%; S-50%); (NS-75%; S-75%) (NS-100%; S-100%). Study B 
consisted of 3 groups including a C: (NS-C; S-C); (NS-LPS-KA; S-LPS-KA) (NS-H; S-H). All rat 
pups were sacrificed on PND 16 by means of a sharp guillotine to collect hypothalamic tissue to assess 
prostaglandin E2 (PGE2) and its receptor prostaglandin EP3 receptor (EP3R) concentrations. 
4.1 STUDY A: PRELIMINARY DOSE OPTIMIZATION 
Our findings for study A showed that all the doses resulted in febrile convulsions, however the higher 
NS-75% and NS-100% doses resulted in more severe stage 4 and 5 tonic-clonic convulsions which 
resulted in an average survival rate of 33% and 0% respectively. The lower NS-25% and NS-50% 
doses resulted in less severe seizures consisting of myoclonic jerks and animals falling on their sides, 
from which many pups recovered, thus experiencing a higher average survival rate of 100% and 67% 
respectively. The average survival rates of the pups were significantly dose dependant. Pups injected 
with higher doses of LPS-KA, experienced more severe seizures, which significantly correlated with a 
lower survival rate and greater drop in oral temperature. The temperature assessment showed an 
overall average dose-dependent decrease of 3.27 °C and 4.47 °C for the NS-75% and NS-100% doses 
and a 2.97 °C and 3.43 °C drop for the NS-25% and NS-50% doses respectively, as opposed to an 
increase despite keeping a consistent room temperature of 30 °C. This finding contradicted the 
previous study by Heida et al. (2005) (26) who found increased temperatures, but agreed with a study 
done by Krakauer et al. (2010) (50) who found a similar drop in body temperature when administering 
high doses of LPS (50). Krakauer et al. (2010) (50) injected 7-10 week old male Balb/c mice with 80 
µg/kg LPS, which resulted in hypothermia and a survival rate of only 52% (50). Thus the possible 
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mechanism for the observed temperature drop may be due to the LPS, a gram-negative bacterial 
endotoxin that induces fever by triggering the synthesis and release of proinflammatory cytokines 
interleukin-1 beta (IL-1β), interleukin-6 and tumour-necrosis factor alpha by the innate immune 
system through toll-like receptors in the periphery (6, 35, 51-53). Hyperproduction of these 
proinflammatory cytokines has been shown to increase vascular permeability, and lead to an increase 
in proinflammatory cascades that may result in vascular collapse and ultimately systemic shock (54-56). 
We thus speculate that the hypothermia experienced in particular by our higher dose pups, was thus 
likely due to systemic toxic shock via the excessive production of these proinflammatory cytokines. 
This coincides with the fact that many pups that were injected with high doses of LPS-KA died. Pups 
injected with higher LPS-KA doses felt cool, stiff to the touch, and appeared sickly with decreased 
mobility further suggesting hypothermia and systemic shock. 
 
In addition, the high mortality rate of the higher dose LPS-KA pups is thought to be due to extensive 
brain lesions, accompanied by neuronal loss and damage associated with the high doses of KA, a 
glutamate agonist that has been shown to increase intracellular calcium ion (Ca2+) concentrations (29, 57-
60). Glutamate is the predominant excitatory neurotransmitter of the adult mammalian brain (61, 62), but 
in excess, glutamate stimulates the influx of Ca2+ leading to its subsequent uptake by mitochondria, 
resulting in neuronal damage and eventual cell death, known as excitotoxicity (63-65). Under normal 
circumstances however, gamma-aminobutyric acid (GABA) controls glutamate transmission through a 
negative feedback mechanism by activating GABA receptors to regulate chloride and potassium ions, 
and decrease Ca2+ in order to modulate glutamate effects (6, 66-68). Excess IL-1ß produced during febrile 
seizures however has been shown to decrease levels of GABA receptor mediated currents, therefore 
further establishing a glutamate-GABA imbalance contributing to seizure generation and the high 
mortality rates (6, 44, 68, 69). High doses of LPS-KA thus result in a twofold excess production of 
proinflammatory cytokines, specifically IL-1β which triggers both fever producing pyrogens, and 
convulsion inducing neurotransmitter imbalances (5, 70-73). 
 
Furthermore, our findings show that exposure to prenatal stress (S) during the third trimester 
exacerbated seizure progression in all the doses. The higher S-75% and S-100% doses resulted in more 
severe stage 5 repeated severe tonic-clonic convulsions, followed by a 2.63°C and 4.17°C drop in oral 
temperature respectively, leading to a lower survival rate of 33% for both doses. Although the lower 
S-25% and S-50% doses resulted in less severe seizures than the higher doses, they were significantly 
more severe than their NS counterparts, displaying myoclonic jerks and tonic convulsions with most 
animals falling on their sides, with a drop in temperature of 2.50°C and 3.10°C resulting in a survival 
rate of 67% and 33% respectively. These findings are in line with previous studies conducted in our 
laboratory by Qulu et al. (2012) (3), Cassim et al. (2015) (23) and Mkhize et al. (2017) (35) who found 
exacerbated stress responses.  
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The effect of prenatal stress on the brain of the offspring is well documented, as is the resultant 
dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis (37, 74-76). Maternal malnutrition, stress, 
or trauma during pregnancy has been shown to result in dysregulation of the foetal HPA axis through 
downregulation of the protective enzyme 11beta-hydroxysteroid-dehydrogenase 2 in the maternal 
placental barrier, thus allowing increased entry and exposure of the foetus to maternal glucocorticoids 
(37). Excess cortisol (corticosterone in rats), exposure in utero is associated with increased activity of 
the offspring’s HPA axis, and the now altered and over stimulated HPA axis often malfunctions 
resulting in higher than normal basal cortisol concentrations (37-39). Cortisol is important for the 
maturation of most foetal organ systems, but in excess it ultimately promotes the downregulation of its 
receptors (38-43). This dysregulation resulting in less cortisol uptake diminishes the immune system’s 
capacity to respond to its anti-inflammatory actions, resulting in an increased proinflammatory 
response (43). This ultimately leaves the new-born more sensitive to future stress and more prone to 
infection than non-prenatally stressed neonates (38-43). This overstimulation of the HPA axis could 
explain why the S animals had exacerbated seizure severity, a greater drop in oral temperature and 
lower survival rates than their NS counterparts. 
 
The neurochemical analyses supported behavioural findings by showing that NS-LPS-KA dosed pups 
experienced a dose-dependent increase in PGE2 concentrations probably due  to upregulated IL-1β 
levels associated with febrile seizure progression. Excess IL-1β has been shown to compromise the 
blood brain barrier, thereby crossing over into the central nervous system where it competitively binds 
to interleukin-1 receptor 1 and triggers cyclooxygenase-2 (COX-2) to catalyse the conversion of 
arachidonic acid into the pyretic prostaglandin PGE2, that subsequently induces the preoptic nuclei of 
the hypothalamus to increase core temperature (5, 8-12, 71, 77). On the contrary however, prenatal stress 
lead to a decreased expression of PGE2 in the S-LPS-KA pups which was particularly evident at high 
doses of LPS-KA. My previous unpublished work in our laboratory on LPS and KA treatment alone 
however showed prenatal stress increased the concentrations of PGE2 in animals injected with only 
LPS, but that prenatal stress decreased PGE2 concentrations in pups injected with only KA. We thus 
attribute the decreased PGE2 concentrations of the S-LPS-KA animals to the KA treatment, and not 
the LPS. This finding contradicts previous work done by Kawaguchi et al. (2005) (15) who showed that 
PGE2 levels were markedly increased 24 hs after KA injection (15). It has however been shown that if 
embryonic development is disturbed, such as during prenatal stress, PGE2 concentrations may fall 
below normal base levels (78), thus suggesting a possible explanation for the decreased PGE2 
concentrations of the S-LPS-KA pups. The decreased PGE2 concentrations could also likely be due to 
its relatively short half-life, whereas upregulation of its receptor expression takes place over a long 
time period (79). The lower PGE2 concentration amongst S-LPS-KA pups could also be due to its 
numerous receptor subtypes that each would have increased their subsequent uptake of PGE2 (80), 
thereby limiting freely available PGE2.  
40 
 
Another point to consider is that PGE2 is not catabolized in the brain of mammals, but rather in the 
lungs, kidney and the liver, and thus it has to be transported out of the brain tissue (79, 81), further 
limiting freely available PGE2. A high enough brain-to-blood PGE2 gradient has been shown to 
facilitate a net efflux of PGE2 (79, 82, 83) as is experienced in animals after KA injection, particularly 
those that have also undergone prenatal stress, thus further upregulating PGE2 efflux. 
Although prenatal stress did not appear to affect the survival rate of the pups, it significantly affected 
seizure severity and the relative PGE2 concentrations, which may have played a major role in the 
increased deaths of animals at the higher doses. Thus a 25% dose of 50 µg/kg LPS and 0.44 mg/kg KA 
was selected to induce febrile seizures as this proved sufficient to induce seizures while maintaining a 
relatively high survival rate. The 25% dose significantly decreased the drop in temperature, seizure 
severity and duration, and resulted in a higher survival rate. 
4.2 STUDY B: RAT MODELS OF FEBRILE SEIZURE STUDY 
Our findings for study B showed that both the modified LPS-KA and H models were successful in 
inducing febrile seizures. Animals treated with LPS-KA developed significantly more severe seizures 
than the H animals, and in both models, prenatal stress significantly exacerbated seizure severity, with 
the S-LPS-KA and S-H animals experiencing more severe seizures than their NS counterparts. The 
NS-LPS-KA pups experienced moderate stage 3 and 4 seizures consisting of myoclonic jerks and 
clonic convulsions with many falling over onto their sides, while the S-LPS-KA pups experienced 
significantly more severe stage 4 and 5 seizures consisting of tonic-clonic convulsions with almost all 
animals falling over. The NS-LPS-KA pups showed a decrease of 2.99°C in oral temperature, and 
although this behavioural result again contradicted Heida et al. (2005) (26), it agreed with the study by 
Krakauer et al. (2010) (50) who found that LPS caused hypothermia (50). As previously discussed, the 
proposed mechanism for the decrease in oral temperature may be due to excessive production of 
proinflammatory mediators that lead to toxic systemic shock (54-56). The S-LPS-KA pups exhibited a 
slight increase in temperature, which coincides with the norm for LPS injection. We believe that the S-
LPS-KA pups exhibited an increased temperature compared to their NS counterparts due to an 
exacerbated stress-induced response to LPS. This lead to an exacerbated production of IL-1ß known to 
induce fever by triggering COX-2 to catalyses the conversion of arachidonic acid into PGE2 (11), which 
left the S animals more prone to developing a fever than NS counterparts to the same stressor (8, 38). 
The neurochemical results supported the behavioural findings by showing an increased concentration 
in both PGE2 and EP3R for the NS-LPS-KA pups, but as before a decrease in PGE2 concentration for 
the S-LPS-KA pups. Interestingly, the S-LPS-KA pups expressed a greater increase in its receptor 
EP3R concentrations than the NS-LPS-KA pups. The greater increase in EP3R expression suggests an 
initially greater increase in PGE2 concentration, while the recorded decrease in PGE2 concentration 
again suggests an exacerbated stress effect leading to a high brain-to-blood gradient, resulting in its net 
efflux out of the brain tissue as previously discussed (79, 82, 83). 
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The H model produced 100% seizure success, with 100% survival. The NS-H pups experienced mild 
to moderate stage 2 and 3 seizures consisting of facial automations, loss of posture and myoclonic 
jerks, while the S-H pups experienced more severe stage 4 seizures consisting of myoclonic jerks and 
clonic convulsions. NS-H and S-H pups experienced a significant rise in oral temperature of 4.76°C 
and 5.11°C respectively, which are symptoms associated with fever, however our neurochemical 
analysis did not support this finding with regards to increased PGE2 concentrations. Although prenatal 
stress exacerbated seizures, it lead to a decrease in PGE2 concentrations. Prenatal stress did however 
lead to an increase in the receptor EP3R expression, which we again attribute to an initially increased 
production of PGE2 through upregulated IL-1ß stimulation, after which an overall net efflux of excess 
PGE2 out of the brain occurred (79, 82, 83). This would explain the decreased PGE2 concentration and 
increased EP3R expression at the time of decapitation for the S-H pups compared to the NS-H pups. 
Although the H model was successful in inducing behavioural seizures, we postulate it was due to a 
different mechanism than that of the LPS-KA infection model. Elevated body temperature due to 
hyperthermia is known to result in an increased rate of breathing known as hyperventilation, which is 
known to raise pH levels resulting in neuronal excitability (84-87). 
 
Based on these findings, we thus suggest the use of the modified LPS-KA model for future studies of 
the mechanism of infection-induced fever resulting in convulsions. This model accurately mimics an 
infection that predisposes children to febrile seizures, as well as the predisposition to future 
complications such as temporal lobe epilepsy. If one needs merely to mimic a fever in the absence of 
infection, followed by convulsions, we suggest the H model due to it being less invasive, and ensuring 
a higher survival rate. We do recommend however that both models be further studied for a more 
thorough understanding of the mechanisms involved. 
 
5 CONCLUSION 
Animal models are vital tools in understanding the mechanism that potentiate febrile seizures, as well 
as numerous other human conditions, and are essential in developing precautionary and therapeutic 
strategies, and in the preclinical development of drugs to combat these conditions. Due to the diverse 
genetic makeup of children, and the presence of many uncontrollable external factors, i.e. prenatal 
stress, it would be impossible to effectively demonstrate the complete mechanisms and consequences 
related to febrile seizures if not for animal models. By refining the Heida et al. (2005) (26) LPS-KA 
model, we achieved 100% febrile seizure success, while significantly reducing mortality rates. These 
simple, non-reoccurring, benign seizures more accurately represent the simple febrile seizures most 
often experienced by otherwise healthy young children. 
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10.3 APPENDIX C 
Study A: Preliminary Toxicity Test Behavioural Results. Table containing average data for change in 
oral temperature, seizure severity and survival rate. 
 Non-Stressed Stressed 
 Change in 
oral 
Temperature 
Average 
Seizure 
Severity 
Average 
Survival 
percentage 
Change in 
oral 
Temperature 
Average 
Seizure 
Severity 
Average 
Survival 
percentage 
Control -0.73°C 0.00 100.00% -0.60°C 0.00 100.00% 
25% -2.97°C 2.33 100.00% -2.50°C 3.33 83.30% 
50% -3.43°C  3.33 83.33% -3.10°C 3.67 66.58% 
75% -3.27°C 4.00 66.67% -2.63°C 4.67 22.10% 
100% -4.47°C 4.67 7.00% -4.17°C 5.00 29.15% 
Study A: Preliminary Toxicity Test Behavioural Results. Change in Oral Temperature, Seizure Severity and 
Survival. Initial and post treatment oral temperature was measured for each pup, thereafter seizers were scored 0 
– no response, to 5 – repeated severe tonic-clonic convulsions on a Racine scale. Survival was regarded as 
surviving until sacrifice. n = 3/group. 
 
10.4 APPENDIX D 
Study B: Febrile Seizure Rat Model Comparison: Behavioural Results. Table containing average data for change 
in oral temperature, seizure severity and survival rate. 
 Non-Stressed Stressed 
 Change in 
oral 
Temperature 
Average 
Seizure 
Severity 
Average 
Survival 
percentage 
Change in 
oral 
Temperature 
Average 
Seizure 
Severity 
Average 
Survival 
percentage 
Control -0.19°C 0.00 100.00% -0.17°C 0.00 100.00% 
LPS-KA -2.99°C 3.50 76.00% +0.04°C 4.43 55.00% 
H +4.76°C 3.14 100.00% +5.11°C 4.00 100.00% 
Study B: Febrile Seizure Rat Model Comparison: Behavioural Results. Change in Oral Temperature, Seizure 
Severity and Survival. Initial and post treatment oral temperature was measured for each pup, thereafter seizers 
were scored 0 – no response, to 5 – repeated severe tonic-clonic convulsions on a Racine scale. Survival was 
regarded as surviving until sacrifice. n = 7/group. 
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10.5 APPENDIX E 
Figure 3.1 Study A: Preliminary Toxicity Test Behavioural Data Significance. Oral temperature and 
seizure severity for the toxicity study was assessed for NS and S animals receiving different doses of 
LPS and KA. 
 
Oral Temperature
NS-C vs NS-25% p=0.0360 
NS-C vs NS-50% p=0.0063 
NS-C vs NS-75% p=0.0116 
NS-C vs NS-100% p=0.0001 
S-C vs S-50% p=0.0130  
S-C vs S-100% p=0.0003 
 
Seizure Severity 
NS-C vs NS-25% p=0.0014 
NS-C vs NS-50% p<0.0001 
NS-C vs NS-75% p<0.0001 
NS-C vs NS-100% p<0.0001 
S-C vs S-25% p<0.0001  
S-C vs S-50% p<0.0001 
S-C vs S-75% p<0.0001  
S-C vs S-100% p<0.0001 
NS-25% vs NS-75% p=0.0342 
NS-25% vs NS-100% p=0.0014 
S-25% vs S-100% p=0.0342 
 
Figure 3.2 Study A: Preliminary Toxicity Test Survival Rate Significance. The survival rate was 
assessed for NS and S animals receiving different doses of LPS and KA. 
NS-C vs NS-100% p=0.0151 NS-25% vs NS-100% p=0.0151 
 
Figure 3.3 Study A: Preliminary Toxicity Test PGE2 Concentration. The concentration of PGE2 was 
assessed for NS and S animals receiving different doses of LPS-KA. 
NS-C vs NS-25% p=0.0344 
NS-C vs NS-50% p=0.0128 
NS-C vs NS-75% p<0.0001 
NS-25% vs NS-75% p=0.0047 
NS-50% vs NS-75% p=0.0131  
NS-50% vs S-50% p=0.0131 
S-C vs S-75% p=0.0027 
S-25% vs S-75% p=0.0008 
S-50% vs S-75%  p=0.003 
S-75% vs S-100% p=0.048 
 
Figure 3.4 Study B: Febrile Seizure Rat Model Comparison: Change in Oral Temperature significance. 
Data assessed for NS and S animals undergoing either LPS-KA or H induced febrile seizures 
NS-C vs NS-LPS-KA p<0.0001 
NS-C vs NS-H p<0.0001 
S-C vs S-H p<0.0001 
NS-LPS-KA vs NS-H p<0.0001 
NS-LPS-KA vs S-LPS-KA p<0.0001 
S-LPS-KA vs S-H p<0.0001 
 
51 
 
Figure 3.5 Study B: Febrile Seizure Rat Model Comparison: Average Seizure Severity significance. 
Data assessed for NS and S animals undergoing either LPS-KA or H induced febrile seizures. 
NS-C vs NS-LPS-KA p=0.0416 
S-C vs S-LPS-KA p=0.0003 
NS-C vs NS-H p=0.0143 
S-C vs S-H p=0.0052 
 
Figure 3.6 Study B: Febrile Seizure Rat Model Comparison: Significant Survival Rates. Data assessed 
for NS and S animals undergoing either LPS-KA or H induced febrile seizures. 
S-C vs S-LPS-KA p=0.0322 S-LPS-KA vs S-H p=0.0322 
 
Figure 3.7 Study B: Febrile Seizure Rat Model Comparison: Significant PGE2 and EP3R correlation. 
Data assessed for NS and S animals undergoing either LPS-KA or H induced febrile seizures. 
NS-H EP3R vs S-H EP3R p=0.0153  
NS-H PGE2 vs NS-H EP3R p=0.0394 
S-C EP3R vs S-H EP3R p=0.0219 
S-C PGE2 vs S-C EP3R p=0.0272 
NS-LPS-KA PGE2 vs NS-LPS-KA EP3R p=0.0363 
S-LPS-KA PGE2 vs S-LPS-KA EP3R p=0.0423 
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CHAPTER THREE 
Chapter three consists of a synthesis followed by a recommendations section from my personal 
experience with this study. 
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SYNTHESIS 
Febrile seizures are the most common type of seizures experienced by infants and young children 
between the ages of 3 months to 6 years. Febrile seizures are often triggered by a fever, usually 
occurring after the onset of a systemic infection. Southern African has shown a growing prevalence of 
febrile seizures due to numerous risk factors, i.e. inadequate medical facilities and malnutrition. A 
seizure is defined as sudden, and uncontrolled electrical firing of neurons that may translate into 
uncontrolled convulsions of the body, and or altered consciousness. Seizures that result in convulsions are 
usually tonic clonic seizures and involve rhythmical jerking movement of one’s body, or part thereof. Tonic 
seizures occur when the muscles suddenly become stiff, and atonic seizures occur when the muscles suddenly 
become relaxed. Both tonic and atonic seizures are brief, and don’t induce convulsions, but often result in the 
person falling over. Absence seizures result in a moment of blank unresponsiveness. The patient is often 
unaware that they are having an absence seizure, as there are no physical signs of convulsing or change in 
muscle tension. 
 
Febrile seizures occur with the activation of the immune system to release proinflammatory cytokines 
which subsequently induce a fever. The increased release of these cytokines lead to a neurotransmitter 
imbalance in the brain, causing neuronal hyper-excitability leading to convulsions. The immune 
system is the body’s defence line that protects it from invading pathogens via eliciting an 
inflammatory response to fight and remove these invading pathogens. During a febrile seizure, there is 
an overactivation and release of proinflammatory cytokines that compromise the protective blood 
brain barrier, thus allowing these proinflammatory cytokines to enter the brain. Proinflammatory 
cytokines are small protein molecules that are released from immune system cells to convoy a 
chemical message to initiate an inflammatory response. Increased proinflammatory cytokines in the 
brain, particularly in the preoptic area of the hypothalamus, over stimulate neuronal cells and 
enzymes, such as cyclooxygenase-2, leading to an increase in core body temperature, resulting in 
fever. Enzymes are another type of protein molecule, but these act as catalysts for chemical reactions, 
rather than just messengers. The enzyme cyclooxygenase-2 in particular catalyses the production of 
prostaglandin E2. Prostaglandins are lipid metabolites that play a major role in inflammation and pain 
in the body. Fever is triggered in the preoptic area of the hypothalamus by prostaglandin E2 binding 
prostaglandin 3 receptors to inhibit preoptic warm-sensitive neuron signals, thus preventing heat loss, 
and increasing cold-sensitive neuron signals, thus enhancing heat production and retention. The 
hypothalamus is split into 4 main regions, each responsible for a number of functions from regulating 
body temperature, sleep and appetite, to hormone release and emotional controls. The preoptic nuclei 
is found within the rostral most part of the hypothalamus, and is most often referred to as the 
thermoregulatory hub as well as the fever centre. Excess proinflammatory cytokines in the brain also 
lead to other complications such as neurotransmitter imbalances, resulting in unstable membrane 
potentials, and neuronal death due to cell overactivation. 
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In order to investigate the potential consequences of febrile seizures, the human condition was 
mimicked in Sprague-Dawley rats via a two-step method to induce fever, and then convulsions. A 
preliminary toxicity study was carried out to determine the ideal dosage of drugs to use in order to 
induce febrile seizures, while maintaining a relatively high survival rate. To induce an infection like 
reaction, rats were injected with lipopolysaccharide (LPS) the major component of the outer wall 
membrane of Gram-negative bacteria. LPS induces a strong defensive response from animal immune 
systems, by triggering enzymes that catalyses the processes leading to a fever like situation. Kainic 
acid (KA) is an excitotoxic and convulsive neurochemical that causes generalized tonic-clonic 
convulsions, and was thus used to mimic the convulsion experienced during a febrile seizure. KA was 
injected 2 h 30 min after the initial LPS injection to allow for the rise in temperature. This model of 
mimicking febrile seizes has been invaluable in studying the causes and progression of the disorder, 
but it has an extremely high mortality rate. We thus refined the model by reducing the dose of LPS and 
KA injected to 25% of the original Heida et al. (2005) model dose. By reducing the dose for the 
model, we were able to effectively mimic febrile seizures, while maintain a high survival rate. 
 
Aside from refining the Heida et al. (2005) model, we also looked into introducing a new rat model of 
febrile seizure to our laboratory. This new model was based on previous work done by Jiang et al. 
(1999) and Yagoubi et al. (2015) who showed that extended exposure to a hyperthermic environment 
can induce febrile seizures by increasing core body temperatures beyond threshold temperatures 
required to evoke febrile seizures. These heat induced seizures are often more subtle than those 
induced by chemoconvulsants, and thus we aimed to refine and introduce the model to our laboratory 
as a less invasive method for study febrile seizures. The model was effective in mimicking seizures, 
and maintaining a high survival rate, however it was inefficient in correctly mimicking fever 
progression that occurs before a febrile seizure onset as a result of infection. 
 
Our work, as with previous work done in our laboratory by Qulu et al. (2012), Cassim et al. (2015) 
and Mkhize et al. (2017) showed that exposure to prenatal stress during the third trimester exacerbated 
febrile seizures in rat offspring. Prenatal stress accounts for all types of stress experienced by pregnant 
mothers, with the most prominent effects occurring during the last trimester. In order to assess the 
effects of prenatal stress in our study, we subjected half of our pregnant dams to restraint stress during 
the third trimester. This consisted of placing the pregnant dams in rodent restrainers for 1h a day for a 
total of 7 days. The pups from the stressed dams then underwent the same procedures as the non-
stressed pups to induce febrile seizures. Prenatal stress lead to greater changes in temperature, more 
severe seizures, and longer recovery times. Prenatal stress however did not seem to effect the 
upregulation of prostaglandins responsible for fever generation, however it did lead to significantly 
increased prostaglandin receptors concentrations. 
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RECOMMENDATIONS 
One thing to be learnt from this study is the need to religiously preform trial runs before commencing 
with the main study. Each animal model used should always bear in mind the 3 R’s, described by 
nc3Rs.org., i.e. Replacement, Reduction and Refinement. Where replacement is impossible, as such 
with total body mechanism studies, animals should be reduce by properly refining all experiments. 
 
The LPS-KA model has long been used in research laboratories all around the world, and has proved 
invaluable in understanding the pathophysiology of febrile seizures. Through iteration, we managed to 
overcome some of its shortfalls and have thus made a list of suggestion for this model. 
• Reduce the dose of LPS and KA if possible. 
• LPS and KA should always be made at most 3 days before injections, and stored frozen in 
aliquots in air tight glass containers, protected from light. 
• LPS and KA, as with all drugs should always be administered at room temperature. Allow the 
solution to thaw and then reach room temperature after removing from the fridge/freezer. 
• Placing the rat pups in a small container on ice for a few minutes’ assists in increasing body 
temperature naturally. Rat pups should not be kept on ice for an extended period of time. 
The hyperthermic model proved to be useful in inducing seizures, and maintaining survival, however 
gene analysis showed that the pyrogenic prostaglandin and its receptor were not fully stimulated, as is 
found with fever occurring naturally due to an underlying infection. An injection of LPS prior to heat 
treatment could prove quite useful in inducing cytokine release, along with an increased core body 
temperature. This could result in more realistic febrile seizures, without the excessive brain cell 
damage caused by injection of KA. 
 
Given an unlimited budget, it would have been ideal to run multiple gene analysis test. Testing for 
interleukin-beta (IL-1ß), interleukin-1receptor antagonist (IL-1ra), interleukin-6 (IL-6), tumour 
necrosis factor-alpha (TNFα), corticosterone, cyclo-oxygenase-2 (COX-2) and numerous 
prostaglandin by-products would have given a better overview. Other than brain hypothalamic tissue, 
liver and kidney tissue should also be analysed. We attempted to collect trunk blood, but our animals 
were too small and thus sufficient volumes of blood were not obtained. 
 
Animal models of febrile seizures can also be translated into lower class non-mammalian animals such 
as the fruit fly, the zebrafish, and the worm (nematode Caenorhabditis elegans). These models could 
prove to be more time and cost effective.  
 
A final recommendation would be the implementation of an automated scoring software programme, 
this would limit bias of visual scoring thereby standardizing scoring parameters. 
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CHAPTER FOUR 
Chapter four contains all relevant appendices for the thesis, including the ethics certificate and in-
depth descriptions on the methods used for the ELISA and PCR assays. 
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APPENDICES 
APPENDIX A: ETHICAL CLEARANCE CERTIFICATE 
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APPENDIX C 
Full description of the dose study postnatal handling of the different groups. 
PRELIMINARY TOXICITY STUDY 
On postnatal day (PND) 14, pups were removed from their dams and separated into five study groups 
including a control. Each group of animals received a different percentage of the original Heida et al. 
(2005) (1) dose of both lipopolysaccharide (LPS) and kainic acid (KA) to induce febrile seizures. All 
injections were preformed intraperitoneally (i.p.) using a 29G 0.5mm insulin needle. 
CONTROL(C) 
The control groups, NS-C and S-C were injected twice with 10 ml/kg of plain saline solution 2.5 hours 
apart to compensate for any additional stress experienced by the injections in the experimental groups. 
GROUP 25% 
This group received 25% of the literature prescribed 200 µg/kg LPS and 25% of the 1.75 mg/kg KA 
prescribed dose (1-3). Pups in this group were injected with 50 µg/kg LPS dissolved in 10 ml/kg saline 
followed by a second injection 2.5 hours later of 0.44 mg/kg KA dissolved in 10 ml/kg saline. 
GROUP 50% 
This group received 50% of the literature prescribed 200 µg/kg LPS and 25% of the 1.75 mg/kg KA 
prescribed dose (1-3). Pups in this group were injected with 100 µg/kg LPS dissolved in 10 ml/kg saline 
followed by a second injection 2.5 hours later of 0.88 mg/kg KA dissolved in 10 ml/kg saline. 
GROUP 75% 
This group received 75% of the literature prescribed 200 µg/kg LPS and 25% of the 1.75 mg/kg KA 
prescribed dose (1-3). Pups in this group were injected with 150 µg/kg LPS dissolved in 10 ml/kg saline 
followed by a second injection 2.5 hours later of 1.31 mg/kg KA dissolved in 10 ml/kg saline. 
GROUP 100% 
Pups in this group received the full literature prescribed dose, i.e. 200 µg/kg LPS dissolved in 10 
ml/kg saline followed 2.5 hours later by 1.75 mg/kg KA dissolved in 10ml/kg saline (1-3). 
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Full description of the model study postnatal handling of the different groups. 
POSTNATAL HANDLING AND FEBRILE SEIZURE INDUCTION 
On postnatal day (PND) 14 both the stressed (S) and the non-stressed (NS) rat pups were removed 
from their dams and separated into four main febrile seizure induction study groups, and a control (C) 
group. All injections were preformed intraperitoneally (i.p.) using a 29G 0.5mm insulin needle. 
CONTROL (C) 
The control groups, NS-C and S-C were injected twice with 10 ml/kg of plain saline solution 2.5 hours 
apart to compensate for any additional stress experienced by the second injection in the experimental 
groups. 
LIPOPOLYSACCHARIDE AND KAINIC ACID (LPS-KA) GROUP 
The pups in this group were injected with the preselected dose (25%) of the original Heida et al. 
(2005)(1) model. The pups in this group, NS-LPS-KA and S-LPS-KA were injected i.p. with 50µg/kg 
of LPS dissolved in saline 10ml/kg, followed by a second i.p. injection 2.5 hours later of 0.4375 mg/kg 
KA dissolved in saline 10ml/kg. 
HEAT (H) INDUCED GROUP 
The heat induced groups NS-H and S-H, were exposed to heat to induce a fever like situation . To 
induce hyperthermia, pups were placed into clear plastic containers with perforated upper sides and 
lids to allow for sufficient ventilation. The container floor was lined with polystyrene to prevent the 
pups feet from burning, and was changed between each trial to minimise additional stress. The 
container was submerged into a water bath warmed at 55-60°C. The rats were kept in this 
hyperthermic situation for about 20 min to allow for a rise in their core temperature. Once a myoclonic 
jerk was experienced, the pup was removed and transferred back to room temperature where the 
febrile seizure was assessed. The pup was cooled, rehydrated, and dried off before being returned to its 
home cage. 
 
References: 
1. Heida JG, Teskey GC, Pittman QJ. Febrile convulsions induced by the combination of 
lipopolysaccharide and low-dose kainic acid enhance seizure susceptibility, not epileptogenesis, in 
rats. Epilepsia. 2005;46(12):1898-1905. 
2. Qulu L, Daniels WM, Mabandla MV. Exposure to prenatal stress enhances the development 
of seizures in young rats. Metab Brain Dis. 2012;27(3):399-404. 
3. Cassim S, Qulu L, Mabandla MV. Prenatal stress and early life febrile convulsions 
compromise hippocampal genes MeCP2/REST function in mid-adolescent life of Sprague-Dawley 
rats. Neurobiology of learning and memory. 2015;125:195-201. 
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APPENDIX D 
Full description of the ELISA protocol followed for this study. 
COMPETITIVE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) 
Hypothalamic tissue collected from the dose study animals as well as from the febrile seizure model 
comparison study and assessed using ELISA to detect the concentration of prostaglandin E2 (PGE2) 
concentrations. 
 
The Elabscience PGE2 (Prostaglandin E2) ELISA Kits (E-EL-0034) (Elabscience, Wuhan, China) 
were used for both studies, and thus the procedure for the pre-study and the main study were the same. 
The overall ELISA procedure is comprised of three main tasks, sample collection, assay procedure, 
and then determining the optical density. The Wash Buffer was added to a BioTek ELx50 plate washer 
(BioTek, Highland Park, USA) to aspirate and wash the plate. The plate was incubated in an oven at 
37°C. The optical density was read at 450nm in a SPECTROstar Nana absorbance plate reader. (BMG, 
Labtech Ortenberg, Germany). 
 
The ELISA reagents were prepared according to the manufactures manual, shown below the reference 
standard diluted in serial from the supplied 2000pg/mL down to 31.25 as shown below. 
ELISA reagent preparation 
Reagent Diluent Dilution 
ratio 
Time before 
use 
Concentrated wash buffer Distilled water 1:25  
Biotinylated detection Ab 
working solution 
Biotinylated detection Ab 
diluent 
1:100 15 min 
Concentrated HRP 
conjugate 
Concentrated HRP diluent 1:100 15 min 
Reference standard Reference standard and 
sample diluent 
2:1 serial 
dilution 
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Elisa standard serial dilution 
 
 
To prepare the samples to be homogenised, the collected frozen tissue was allowed to thaw on ice, 
before being diluted in phosphate-buffered saline (PBS) in a 1:9 ratio. All samples were homogenised 
using a sonicator (Qsonica, MODEL CML-4) on ice in their original collection Eppendorf’s, and then 
centrifuged (Hermle LASEC, Germany) at 5000 x g and the supernatant was collected for the assay 
procedure. 
ASSAY PROCEDURE: 
• A volume of 50 µL of each standard was added in duplicate side by side into the first two 
columns of the provided 96-well plate, followed by the samples applied in the same manner. 
• An equal volume of the diluted Biotinylated Detection Ab solution was immediately added to 
each well. The plate was then sealed and incubated for 45 min. 
• A wash machine (BioTek, Highland Park USA) was used to aspirate, soak and wash the plate 3 
times. 
• After washing, 100 µL of the diluted HRP Conjugate working solution was added to each well, 
then the plate was sealed and incubated for 30 min. 
• The plate was returned to the wash machine (BioTek, Highland Park USA) and washed 5 times. 
• After washing, 90 µL of the Substrate Reagent was added to each well, the plate sealed and 
incubated for just short of 15 min. 
• Finally, 50 µL of Stop Solution was added to each well in the same order as the Substrate 
Reagent. 
 
The plate was immediately taken to the SPECTROstar Nana (BMG, Labtech Ortenberg, Germany) 
absorbance plate reader to determine optical density at 450nm.  
  
Amount 
transfered uL
• Concentration 
of standard 
pg/mL
500
• 2000
500
• 1000
500
• 500
500
• 250
500
• 125
500
• 62.5
0
• 31.25
Blank
• 0
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APPENDIX E 
Full description of the PCR protocol followed for this study. 
REAL-TIME POLYMERASE CHAIN REACTION (PCR) 
Real time PCR was employed to quantify the expression of prostaglandin EP3 receptor (EP3R) levels 
in hypothalamic tissue collected from the model study animals. The overall polymerase chain reaction 
(PCR) procedure is comprised of three main tasks, isolating the RNA from the tissue samples, 
converting the isolated RNA into complementary DNA (cDNA), and then amplifying the target DNA 
section. 
RNA ISOLATION 
The Zymo Research Quick-RNA™ Miniprep Kit (ZAR1054) kit was used to isolate RNA from our 
tissue samples. The three step protocol from the manufactures manual was followed, which included 
homogenization, clearing and gDNA removal, and RNA purification. The RNA wash buffer 
concentrate was first  reconstituted by adding 104 ml of 95% ethanol to the 24 ml container (Zymo, 
ZAR1054). All centrifugation steps accoutred at 10 000 x g. 
HOMOGENIZATION 
• To prepare the samples to be homogenised, the collected frozen tissue was thawed on ice, before 
adding 300 µl of lyse buffer. All samples weighed less than 20 mg, and all samples were 
homogenised on ice using a sonicator (Qsonica, MODEL CML-4). The sample was then cleared 
of lysate by centrifugation for 1 min.  
CLEARING AND GDNA REMOVAL 
• The supernatant was then transferred into a Spin-Away™ Filter (yellow) in a Collection Tube and 
centrifuged again for 1 minute for further clearing and gDNA removal. The flow through was 
then used for the RNA Purification steps. 
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RNA PURIFICATION 
• Ethanol (98%) was added into the sample in a 1:1 ration to the lyse buffer, thus 300 µl was added 
to the sample and vortexed. 
• This mixture was then transferred to a Zymo-Spin™ IIICG Column1 (green) in a Collection Tube 
and centrifuged for 30 seconds. This time the flow-through was discarded, but the collection tube 
itself was kept.  
• In-column DNase I Treatment was performed to remove all trace DNA. 
• The column was prewashed with 400 µl RNA Wash Buffer then centrifuged for 30 seconds and 
the flow-through discarded. 
• 80 µl of DNase I Reaction Mix was added to each column and incubated at room temperature for 
15 min. The master mix of the DNase I reaction mix was prepared in an Eppendorf tube 
according to the protocol shown below. 
• The sample was then centrifuged for 30 seconds, 400 µl RNA Prep Buffer was added to the 
column and it was again centrifuged for 30 seconds. The flow-through was discarded 
• 700 µl of RNA Wash Buffer was added to the column and centrifuged for 30 seconds. The flow-
through was again discarded 
• 400µl RNA Wash Buffer was added and centrifuged for 2 minutes to ensure complete removal of 
the wash buffer. 
• The Zymo-Spin™ IIICG Column1 (green) columns were carefully transferred into separate 1,5 
ml nuclease-free Eppendorf tubes. 
• 100 µl of DNase/RNase-free water was added directly to the column matrix and centrifuged for a 
final 30 seconds. This concluded the RNA isolation stage. The flow through was kept on ice for 
cDNA synthesis preparation. 
In column DNase I treatment reaction mix 
DNase I Reaction Mix reagents Volume per tube (µL) 
DNase I 5 
DNA Digestion Buffer 75 
Total Volume 80 
CDNA SYNTHESIS 
Samples were converted to cDNA on the same day as the RNA isolation process using the Bio-Rad 
iScript™ cDNA Synthesis Kit (1708891). 
• The eluted RNA concentration was measured for purity using the Nanodrop 2000 from Thermo 
Scientific (Roche, ZA). A purity ration (
A260
A280
) of 1,7 to 2,1 was considered sufficient for 
conversion to cDNA. 
• All RNA was diluted with nuclease-free water to 50ng/µl before conversion to cDNA 
• The samples were prepared in accordance to the iScript cDNA synthesis kit from BioRad in white 
PCR strips. 
• The samples were placed into the thermocycler 2.0 (Roche, ZA) in accordance to the iScript 
cDNA synthesis kit from Bio-Rad. 
• All the samples were then stored overnight at -20°C to be used the following day. 
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Reaction mix used to synthesise cDNA from the extracted RNA 
Component Volume per tube (µL) 
5x iScript Reaction Mix 4 
iScript Reverse Transcriptase 1 
Nuclease-free water 5 
RNA template (100fg -1µg total RNA) 10 
Total Volume 20 
The reaction protocol used to synthesise cDNA from the extracted RNA 
Cycle Time Temperature 
Priming 5 min 25°C 
Reverse transcription 20 min 46°C 
RT inactivation 1 min 95°C 
AMPLIFICATION 
• The PCR primers for the target (EP3R) and reference (GAPDH) genes were eluted to a 100Mm 
stock solution by adding nuclease-free water as per manufacturer instructions. The primer 
sequence and the dilution instructions can be seen below. A further 1:20 primer working dilution 
(50 ng/ul) was then prepared for use in the amplification. The primers were designed on Primer-
BLAST and obtained from Inqaba Biotechnical Industries (Pty) Ltd. 
• The reaction mix to be used for amplification was prepared in white PCR strips, in accordance to 
the iTaq universal SYBR Green supermix (Bio-Rad, ZA) instructions as depicted below. 
• A standard cure was prepared for both the target and reference genes and run in duplicate. 
Samples were also run in duplicate for both primers, i.e. 2x target gene samples and 2x reference 
gene samples. 
• A Roche LightCycler (Roche, ZA) was programmed in accordance to instruction depicted below. 
The reaction mixture was prepared. 
PCR target and reference primers 
Primer NCBI Reference Sequence H2Oµl  
EP3R F NM_012704.1 ATACCTGCTTCCCTGAGTAT  496.67 
EP3R R NM_012704.1 GAGGCCGAAAGAAGATACAA  539.66 
GAPDH F NM_017008.4 AGTGCCAGCCTCGTCTCATA  715.74 
GAPDH R NM_017008.4 GATGGTGATGGGTTTCCCGT  566.07 
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The PCR mix which was used 
Component Volume per tube (µL) 
iTaq universal SYBR Green supermix 10 
Forward primer 2 
Reverse primer 2 
Nuclease-free water 4 
cDNA template 2 
Total Volume 20 
 
The reaction protocol used for the PCR 
Cycle step Temperature Time (sec) Cycles 
Initial incubation 95°C 150 1 
3 step Amplification 95°C 12 
50 60°C 20 
72°C 30 
Melt curve 95°C 30 
1 65°C 60 
97°C 1 
Cooling 40°C 10 1 
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APPENDIX F 
A few personal photos taken throughout the study. 
 
Figure 10.1. Photo A on the left is of a vaginal plug in the vaginal orifice of a female Sprague Dawley rat the 
morning after mating. Photo B on the right is a vaginal smear preformed after successful mating, sperm and 
nucleated epithelial cells are visible. 
 
Figure 10.2. The water bath used to create the hyperthermic environment (H) model. A single rat pup was placed 
into the plastic container lowered into the hot water. The lid and the upper rim of the container were aerated. The 
bottom of the container was lined with polystyrene to prevents the pup’s paws from burning. 
A B 
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Figure 10.3. A group photo of the UKZN Neuroscience and ZuluCortex Club members promoting brain 
awareness in local school communities. 
 
Figure 10.4. A photo of my bored fiancé pretending to be Thanos with the infinity stones, while keeping me 
company at 2 am during my PCR runs. 
